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and observed for an additional period of up to 2 weeks.
Allhigh dosemalemicewere deadbythe end ofweek92.
For each species, 50 animals ofeach sex were placed on
test as controls and fed only the basal laboratory diet.
Mortality rates were dose-related for both sexes of
both species. That incidences of certain tumors were
higherinlowdosethaninhighdosegroupswasprobably
due to accelerated mortality in the high dose group.
In dosed rats of both sexes, statistically significant
incidencesofbladdercarcinomas (combinedincidencesof
papillary carcinomas, squamous-cell carcinomas,
transitional-cell papillomas,transitional-cell carcinomas,
and undifferentiated carcinomas) and olfactory neu-
roblastomas were observed. The combined incidence of
neoplastic nodules oftheliver, hepatocelularcarcinomas,
or mixed hepato/cholangio carcinomas was also signifi-
cant in low dose male rats.
In both male and female dosed mice, the incidence of
bladder carcinomas (combined incidence of carcinomas
NOS, squamous-cell carcinomas, and transitional car-
cinomas) was signiflcant. Theincidence ofhepatocellular
carcinomas was also significant in dosed female mice.
Under the conditions ofthis bioassay, p-cresidine was
carcinogenic to Fischer 344 rats, causing increased inci-
dences of carcinomas and of papillomas of the urinary
bladder in both sexes, increased incidences of olfactory
neuroblastomas in both sexes, and of liver tumors in
males. p-Cresidine was also carcinogenic in B6C3F1
mice, causingcarcinomas oftheurinarybladders inboth
sexes and hepatocellular carcinomas in females.
Synonyms: 2-methoxy-5-methylbenzeneamine; 2-meth-
oxy- 5-methylaniline; 5-methyl-o-anisidine; m-amino-
p-cresol methyl ether; MASO; cresidine
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-143 Bioassay of1,5-
Naphthalenediamine for Possible
Carcinogenicity (CAS No. 2243-62-1)
1,5-Naphthalenediamine, a bicyclic aromatic amine
usedinthedyeindustry,was selectedforbioassaybythe
National Cancer Institute because ofthe high incidence
of bladder cancer reported among dye manufacturing
workers. Aromatic amines are one ofa class ofchemicals
believed to contribute to theincreased cancerriskinthis
industry.
Abioassay of1,5-naphthalenediamine forpossible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 1,5-Naphthalenediamine was admin-
istered in the feed, at either of two concentrations, to
groups of50 male and 50 female animals ofeach species.
The high and low dietary concentrations utilized in the
chronic bioassay were, respectively, 0.1 and 0.05 percent
for rats and 0.2 and 0.1 percent for mice. The compound
wasadministeredinthedietfor103weeks,followedbyup
to 4 weeks ofobservation. Fifty mice ofeach sex and 25
rats of each sex were placed on test as controls. These
animals were observed for up to 110 weeks.
There were no significant positive associations
between the administered concentrations of 1,5-
naphthalenediamine andmortalityineithersexofrats or
mice. In all groups adequate numbers of animals sur-
vived sufficiently long to be at risk from late-developing
tumors.
Among dosed female rats, a statistically significant
increase in endometrial stromal polyps was observed.
Several ofthese tumors underwent malignant transfor-
mation to endometrial stromal sarcomas. The incidence
offemale rats havingeitheradenoma orcarcinomaofthe
clitoral glandwas statistically significant. No neoplasms
were observed at significantly increased incidences in
dosed male rats. Based onlack ofclinical signs orweight
loss, the male rats may have been able to withstand a
higher dose.
In mice, dose-related increases in thyroid neoplasms
were observed in both sexes. The incidence of thyroid
C-cell carcinomas was significant for high dose female
mice. The combined incidences of papillary adenomas,
follicular-cell adenomas and papillary cystadenomas of
the thyroid were significant for mice ofboth sexes. The
incidence ofhepatocellular carcinomas and the incidence
of alveolar/bronchiolar adenomas were each significant
for dosed female mice.
Under the conditions of this bioassay, 1,5-
naphthalenediamine was carcinogenic in female Fischer
344 rats, causing clitoral and uterine neoplasms. 1,5-
Naphthalenediamine was also carcinogenic for B6C3F1
mice, producing thyroid neoplasms in males and neo-
plasms ofthe thyroid, liver, and lung in females. Insuffi-
cientevidencewasprovidedforthecarcinogenicity ofthe
compound in male Fischer 344 rats.
Synonym: 1,5-diaminonaphthalene
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-144 Bioassay of
2-Aminoanthraquinone for Possible
Carcinogenicity (CAS No.117-79-3)
2-Aminoanthraquinone, an intermediate in the syn-
thesis of anthraquinone dyes, was selected for bioassay
by the National Cancer Institute in an attempt to deter-
mine which chemicals may be responsible for theABSTRACTS FROMLONG-TERM CANCER STUDIES, 1976-1992
increased incidence of bladder cancer observed among
workers in the dye manufacturing industry. Aromatic
amines are one ofseveral classes ofchemicals thoughtto
contribute to the increased cancer risk in this industry.
A bioassay of2-aminoanthraquinone for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 2-Aminoanthraquinone was administered
in the feed, at either of two concentrations (except for
female rats), to groups of50 male and 50 female animals
ofeach species. The time-weighted average dietary con-
centrations used in the chronic bioassay were 0.69 and
0.35percentforhighandlowdosemalerats,respectively,
0.2 percent for the treated female rats, and 1.0 and 0.5
percent, respectively, for high and low dose mice ofboth
sexes. After a78-weekperiod ofchemical administration
(80 weeks for high dose mice), observation of the rats
continued for up to an additional 32, weeks and observa-
tion of the mice continued for up to an additional 16
weeks.
In both species adequate numbers of animals in all
groups, except the treated female rats, survived suffi-
ciently long to be at risk from late-developing tumors.
The survival amongtreatedfemale ratswaspoor and, as
a result, no conclusions could be made regarding the
carcinogenicity ofthe compound in these animals.
When male rats having either hepatocellular car-
cinomas orneoplastic nodules ofthe liverwere combined
and theresulting tumorincidenceswere analyzed statis-
tically, there was a significant positive association
between dosage and the incidences of these combined
neoplasms. Hepatocellular carcinomas were observed at
significantly higher incidences when dosed mice were
compared to controls. There was a significantly higher
incidence ofmalignanthematopoietic lymphomas in high
dose female mice when compared to controls.
Under the conditions ofthis bioassay, dietary admin-
istration of 2-aminoanthraquinone was carcinogenic.in
male Fischer 344 rats, causing a combination of
hepatocellular carcinomas and neoplastic nodules ofthe
liver. The compound was also carcinogenic in B6C3F1
mice, causing hepatocellular carcinomas in both sexes
and malignant hematopoietic lymphomas in females.
Synonyms: 2-amino-9,10-anthracenedione; AAQ
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Inadequate Study
Male Mice: Positive
Female Mice: Positive
TR-145 Bioassay of 3-Chloro-p-Toluidine
for Possible Carcinogenicity (CAS No.
95-74-9)
3-Chloro-p-toluidine, a dye intermediate and avicide,
was selected for bioassay by the National Cancer
Institute because of the increased incidence of bladder
cancer observed amongworkers in the dye manufactur-
ing industry. Aromatic amines, of which 3-chloro-
p-toluidine is one example, are among several classes of
chemicals believed to contribute to this increased cancer
risk.
Abioassayforthepossiblecarcinogenicityof3-chloro-
p-toluidine was conducted using Fischer 344 rats and
B6C3F1 mice. 3-Chloro-p-toluidine was administered in
the feed, at either oftwo concentrations, to groups of50
male and 50 female animals of each species. Twenty
animals of each sex and species were placed on test as
controls. The time-weighted average dietary concentra-
tions of3-chloro-p-toluidine administered to rats ofboth
sexeswere3,269and 1,635ppmforthehigh andlowdose
groups,respectively.Thehighandlowdietaryconcentra-
tions of3-chloro-p-toluidine administered to mice were,
respectively,1,200and600ppmformales and600and300
ppmforfemales. The compoundwas administered in the
dietfor78weeks, followedbyan observation period of24
weeks for high dose male rats, 25 weeks for all other
dosed rats, and 12 weeks for mice.
There were no significant positive associations
between the concentrations of 3-chloro-p-toluidine
administered and mortality in either species. Adequate
numbers of animals in all groups survived sufficiently
long to be at risk from late-developing tumors. Mean
body weight depression, relative to controls, was
observed in high dose rats and mice of both sexes,
indicating that the concentrations administered to these
animals may have approximated the maximum tolerated
dosages. The unusual incidences ofnonneoplastic spleen
and liverlesions in high dose rats supports this assump-
tion.
Under the conditions of this bioassay there was no
convincing evidence for the carcinogenicity of 3-chloro-
p-toluidine in Fischer 344 rats or B6C3F1 mice.
Synonyms: 3-chloro-4-methylbenzeneamine; 1-amino-3-
chloro-4-methylbenzene; CPT
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-146 Bioassay ofNithiazide for
Possible Carcinogenicity (CAS No.
139-94-6)
Nithiazide, an antiprotozal compound used in veteri-
narymedicine, was selected forbioassaybythe National
Cancer Institute because of its use and possible per-
sistence in the tissues and eggs of animals raised for
human consumption.
83NTP/NIEHS
Thebioassay ofnithiazide forpossible carcinogenicity
was conducted using Fischer 344 rats and B6C3F1 mice.
Nithiazide was administered in the diet, at either oftwo
concentrations, to groups of 50 male and 50 female
animals ofeach species. Thehighand lowconcentrations
of nithiazide utilized were, respectively, 1,250 and 625
ppm for rats and 5,000 and 2,500 ppm for mice. Dosed
ratsreceived feedcontainingnithiazide for38weeks, and
as a result ofa shortage ofnithiazide, the animals were
not fed the dosed feed for the next 9 weeks. The dosed
feed diet was then resumed and continued for 56 weeks,
after which time a 1-week observation period followed.
Dosed mice received feed containing nithiazide for 61
weeks and, due to a shortage of nithiazide, the animals
were not fed dosed feed for the next 9weeks. The dosed
feed diet was then resumed and continued for 33 weeks,
followed bya1-week observationperiod. Twentyanimals
of each sex and species were placed on test as controls.
Inboth species, adequatenumbersofanimals survived
sufficiently long to be at risk from late-developing
tumors. There was no significant positive association
between dosage and mortality for either rats or mice.
Compound-related mean body weight depression
occurred in both sexes ofeach species.
Statistically significant incidences ofhepatocellular ade-
nomas and carcinomas were found in high dose male mice
butnotinfemalemice.Althoughtheincreasedincidencesof
these tumors in dosed female mice were not statistically
significant,theevidencepresentedwasstronglysuggestive
of carcinogenicity to the liver in female B6C3F1 mice.
Statistically significant increased incidences ofa combina-
tion of mammary and skin fibroadenomas and
cystadenomas NOS were found in the high dose female
rats. No unusual tumors were observed in either species.
Under the conditions of this bioassay, nithiazide was
carcinogenic in male and probably female B6C3F1 mice,
causing a combination ofhepatocellular carcinomas and
hepatocellular adenomas. Nithiazide was also car-
cinogenic in female Fischer344 rats, causing anincrease
in the incidence ofmammary neoplasms. The compound
was not carcinogenic in male Fischer 344 rats.
Synonyms: N-ethyl-N'-(5-nitro-2-thiazolyl) urea;
1-ethyl-3-(5-nitro-2-thiazolyl) urea
Report Date: 1979
Levels of Evidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Positive
Male Mice: Positive
Female Mice: Equivocal
TR-147 Bioassay of Mexacarbate for
Possible Carcinogenicity (CAS No.
315-18-4)
Mexacarbate is one of a group of agricultural
pesticidesthatscientists attheNationalCancerInstitute
noted, in the late 1960's, had not been adequately tested
for carcinogenicity. Mexacarbate has been used as an
insecticide and as a molluscicide for the control ofpests
on lawns, turf, and flowers.
A bioassay of technical-grade mexacarbate for
possible carcinogenicity was conducted using Osborne-
Mendel rats and B6C3F1 mice. Mexacarbate was admin-
istered in the feed, at either of two concentrations, to
groups of50male and 50 female animals ofeach species.
The time-weighted average high and low dietary con-
centrations of mexacarbate were 418 and 209 ppm for
male rats, 678 and 339 ppm for female rats, 654 and 327
ppm for male mice and 135 and 68 ppm for female mice.
After a 78-week period of chemical administration,
observation of rats continued for an additional 33 to 34
weeks and observation of mice continued for 14 to 15
additionalweeks. Foreachspecies,20animalsofeachsex
were placed on test as controls.
All groups except the male control mice survived
sufficientlylongtobeatriskfromlate-appearingtumors.
Because of poor survival of the male control mice, a
pooled control group was used for statistical analysis of
tumor incidence in male mice.
The possibility that female mice in this study did not
receivemaximumtolerateddosagesofmexacarbate should
be considered. Administration ofmexacarbate had no sig-
nificant effect on survival or bodyweights offemale mice.
No neoplasms occurred in statistically significant
increased incidences when dosed rats were compared to
controls.
Amongmalemicesurvivingatleast56weeks,significant
associationswith dietary concentrations were indicatedby
the Cochran-Armitage test forhepatocellular carcinomas,
for subcutaneous fibrosarcomas and for fibromas of the
skin. In none of these cases, however, were these results
supported by significant Fisher exact tests.
Under the conditions of this bioassay, sufficient evi-
dence was not obtained for the carcinogenicity of mex-
acarbate for Osborne-Mendel rats or B6C3F1 mice.
Synonyms: 4-(dimethylamino)-3,5-dimethylphenyl meth-
ylcarbamate; 4-dimethylamino-3,5-xylyl methylcarbamate
Report Date: 1978
Levels of Evidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-148 Bioassay of1-Phenyl-2-thiourea
for Possible Carcinogenicity (CAS No.
103-85-5)
1-Phenyl-2-thiourea was selected for bioassay by the
National Cancer Institute because ofthe structural sim-
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ilarity of this compound to ethylene thiourea, a
tumorigen in hybrid mice (C57BL/6 x C3H/Anf and
C57BL/6 x AKR), and the widespread oral exposure to
this compound when used in classroom demonstrations
ofgenetic polymorphism in taste.
A bioassay of 1-phenyl-2-thiourea for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 1-Phenyl-2-thiourea was administered in
the feed, at either oftwo concentrations, to groups of50
male and50female animals ofeach species. Thehigh and
low concentrations of1-phenyl-2-thiourea utilized in the
chronic bioassay were, respectively, 120 and 60 ppm for
rats and 300 and 150 ppm for mice. Twenty animals of
eachspeciesandsexwereplacedontestascontrols.A78-
week period ofchemical administration was followed by
an additional observation period of26weeks forrats and
13 weeks for mice.
Adequate numbers of animals in all groups survived
sufficiently long to be at risk from late-developing
tumors. Distinct dose-related depression of mean body
weight gain was observed in male and female micewhen
compared with their controls, but growth retardation
was not observed in any dosed rat group. In addition,
since no significant accelerated mortality or other toxic
effects were associated with the dietary administration
of 1-phenyl-2-thiourea to rats, it is possible that the
compound was not administered to these animals at the
maximum tolerated concentrations.
There were no tumors in either sex ofrats or mice for
which a significant positive association could be estab-
lished between chemical administration and tumor inci-
dence.
Under the conditions of this bioassay, 1-phenyl-2-
thiourea was not carcinogenic to Fischer 344 rats or
B6C3F1 mice.
Synonyms: Phenylthiourea; Phenylthiocarbamide;
1-Phenylthiourea; N-Phenylthiourea; PTU
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-149 Bioassay ofN,N'-Diethylthiourea
for Possible Carcinogenicity (CAS No.
105-55-5)
N,N'-Diethylthiourea, a corrosion inhibitor and accel-
erator in elastomer manufacture, was selected for bio-
assay by the National Cancer Institute because of the
structural similarity of this compound to ethylene thio-
urea, a tumorigen in hybrid mice (C57BL/6 x C3H/Anf
and C57BL/6 x AKR).
A bioassay for the possible carcinogenicity of N,N'-
diethylthiourea was conducted using Fischer 344 rats
and B6C3F1 mice. N,N'-Diethylthiourea was admin-
istered in the feed, at either of two concentrations, to
groups of 50 males and 50 females of each species.
Twenty animals of each sex and species, except for 19
male mice, were placed on test as controls. The high and
lowdietaryconcentrations ofN,N'-diethylthioureawere,
respectively, 250 and 125 ppm for rats and 500 and 250
ppm for mice. The compound was administered in the
dietfor103weeks, followed by an observation period of1
week for all dosed groups.
There were no significant positive associations
between the dosages of N,N'-diethylthiourea admin-
istered and mortality in rats or mice of either sex.
Adequatenumbers ofanimalsinalldosegroups survived
sufficiently long to be at risk from late-developing
tumors.Compound-related meanbodyweightdepression
was apparent among dosed male and female mice when
compared totheirrespective controls, indicatingthatthe
concentrations of N,N'-diethylthiourea administered to
mice may have approximated the maximum tolerated
dosages.
Therewere statistically significantelevatedincidences
of follicular-cell carcinomas of the thyroid in high dose
male rats. In addition, therewere statisticallysignificant
elevated incidences ofa combination ofthyroid follicular-
cell carcinomas and follicular-cell adenomas in high dose
male and female rats.
Under the conditions of this bioassay, N,N'-
diethylthiourea was carcinogenic to Fischer 344 rats,
causing follicular-cell carcinomas ofthe thyroid in males
and follicular-cell neoplasms of the thyroid in females.
There was no evidence for the carcinogenicity of the
compound in B6C3F1 mice.
Synonyms: 1,3-diethyl-2-thiourea; 1,3-diethylthiourea
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Negative
Negative
TR-150 Bioassay of Butylated
Hydroxytoluene (BHT) for Possible
Carcinogenicity (CAS No. 128-37-0)
The phenolic antioxidant butylated hydroxytoluene
(BHT) was patented in 1947 and received approval for
use as a food additive and preservative by the Food and
Drug Administration (FDA) in 1954. Since 1959, BHT
has been generally recognized as safe (GRAS) for use in
foods and is one ofthe mostcommonlyused antioxidants
in foods containing fats.
A bioassay of BHT for possible carcinogenicity was
conducted by administering the test chemical in feed to
F344 rats and B6C3F1 mice.
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Groups of 50 rats and 50 mice of each sex were
administered BHT at one of two doses, either 3,000 or
6,000 ppm; the rats for 105weeks and themice for107 or
108 weeks. Matched controls consisted of 20 untreated
rats and 20 untreated mice of each sex. All surviving
animals were killed at the end of administration of the
test chemical.
Mean body weights of the dosed rats and mice were
lower than those ofthe corresponding controls andwere
dose related throughout most of the bioassay. Survival
was notaffected significantlyinthe dosed groups ofrats
ormice, and the survivalwas 60% orgreater in all dosed
orcontrolgroupsofratsandmiceofeachsexattheendof
the bioassay. Sufficient number of animals were at risk
for the development oflate-appearing tumors.
Alveolar/bronchiolar carcinomas or adenomas
occurred in the female mice at a signiflcant incidence in
the low-dose group (P=0.009) but not in the high dose
group, and the incidences were not significantly dose
related (control 1120, low-dose 16/46, high-dose 7/50).
Thus, these lung tumors in the female cannot clearly be
related to the administration of the BHT. No tumors
occurred in eithermale or female rats at incidences that
were significantly higherin dosed groups than in corres-
ponding control groups. Nonneoplastic lesions that may
havebeenrelatedtotheadministration ofthetestchemi-
cal included focal alveolar histiocytosis at increased
incidences in the dosed female rats and various lesions
of the liver at increased incidences in the dosed male
mice.
It is concluded that under the conditions of this bio-
assay, BHT was not carcinogenic for F344 rats or
B6C3F1 mice.
Synonyms: 2,6-di-tert-butyl-p-cresol, BHT
Report Date. 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-151 Bioassay of Lead
Dimethyldithiocarbamate for Possible
Carcinogenicity (CAS No. 19010-66-3)
The lead salt of bis(dimethyldithiocarbamic) acid is
used commercially as arubberacceleratorinapplications
involving natural rubber, and styrene-butadiene,
isobutylene-isoprene, isoprene, and butadiene rubber.
Dithiocarbamate accelerators are known as ultra accel-
erators due to their speed of reaction. They are used
primarily in latexes and rubber cements.
A bioassay oftechnical-grade lead dimethyldithiocar-
bamate for possible carcinogenicity was conducted by
administering thetestchemicalinfeed to F344 (Fischer)
rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered lead dimethyldithiocarbamate at one
of two doses, either 25 or 50 ppm, for 104 or 105 weeks.
Matched controls consisted of20 untreated rats and 20
untreated mice of each sex. All surviving animals were
killed at the end of the period of administration of the
test chemical.
Mean bodyweights ofthe dosed male rats and female
micewere slightlylowerthanthose ofthe corresponding
controls;meanbodyweightsofthedosedfemaleratsand
male mice were essentially the same as those of the
corresponding controls. Survival rats in both species
were unaffected by administration of the test chemical.
The lack of toxicity in both species suggests that a
maximum tolerated dose level may not have been used.
Therefore, the studies may not have been conducted
using maximum sensitivity for the assessment of the
possible carcinogenicity of lead dimethyldithiocarba-
mate.
No tumors occurred in the rats ormice ofeither sex at
incidences that were significantly higher in the dosed
groups than in the control groups.
It is concluded that under the conditions of this bio-
assay, lead dimethyldithiocarbamate was not car-
cinogenic for F344 rats or B6C3F1 mice ofeither sex.
Synonym: ledate
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-152 Bioassay ofEthyl Tellurac for
Possible Carcinogenicity (CAS No.
20941-65-5)
Ethyl tellurac is used in rubber processing where it
functions to acceleratetherateofvulcanization orforma-
tion of sulfur bridges between rubber polymers that
produces modulus or rigidity in the finished product.
A bioassay of technical-grade ethyl tellurac for
possiblecarcinogenicitywas conductedbyadministering
the preparation in feed to F344 rats and B6C3F1 mice.
Groups of50 rats ofeach sexwere administered ethyl
tellurac atoneoftwo doses, either300 or600ppmforthe
males and either 150 or 300 ppm for the females, for 105
weeks.Matched controls consisted of20untreatedratsof
each sex. All surviving rats were killed at 105 weeks.
Groups of50mice ofeach sexwere administered ethyl
tellurac at one oftwo doses, initiallyeither2,500 or5,000
ppm. Due to signs oftoxicity in the dosed animals, these
doses were reduced to 500 and 2,000 ppm, respectively,
starting atweek 41 for the males and at week 38 for the
females. The reduced doses were maintained for 66
weeks for the males; for the females, the reduced doses
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were raised after 3 weeks to 2,000 and 5,000 ppm,
respectively, and maintained atthese levels for66weeks.
The time-weighted average doses for the males were
either 1,255 or 3,132 ppm; for the females, either 2,132 or
4,915 ppm. Matched controls consisted of 20 untreated
mice of each sex. All surviving mice were killed at 106
weeks.
Meanbodyweights ofthedosed groups ofrats ormice
were lower than those of corresponding controls
throughout most or all ofthe bioassay. No other clinical
signs in the rats or mice were clearly related to admin-
istration ofthetestchemical. Survival oftherats andthe
mice was not affected by the chemical, and sufficient
numbers ofallgroupswere atriskforthe development of
late-appearing tumors.
Inthemalerats,mesotheliomas occurred atincidences
thatwere dose related (P=0.012); in direct comparisons,
the incidences of the tumors in the individual dosed
groups were not significantly higher than that in the
control group (controls 0/20, low-dose 2/49, high-dose
8/50). However, the historical-control data atthis labora-
tory indicate an incidence of12/416 (2.9%) in male F344
rats compared with 8/50 (16%) in the male high-dose
group in this study.
In the female rats, no tumors occurred at incidences
that were related to administration ofthe test chemical.
In both male and female mice, adenomas ofthe lacri-
mal (harderian) gland of the eye occurred in the dosed
groups, but not in the corresponding controls (males:
controls 0/17; low-dose 16/46, high-dose 10/49; females:
controls 0/20, low-dose 6/50, high-dose 5/49). The inci-
dences inthedosedgroupswere nothighenoughto show
statistically significant dose-related trends. However, in
direct comparisons of dosed and control groups ofmale
mice,theincidencewasstatisticallysignificantin4thelow-
dose males (P = 0.003). In female mice, direct com-
parisons of dosed and control groups indicated that the
incidence ofthis tumor was not statistically significant.
It is concluded that under the conditions of this bio-
assay,ethyltelluracwasnotcarcinogenicforF344ratsor
B6C3F1 mice of either sex. The incidence of meso-
theliomas in dosed male rats and the incidence of ade-
nomas of the lacrimal (harderian) gland of the eye in
dosed mice of either sex provided evidence which was
suggestive but under the conditions of the bioassay
insufficient to establish the carcinogenicity ofethyl tell-
urac in these animals.
Synonym: tellurium diethyldithiocarbamate
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Equivocal
Female Rats: Negative
Male Mice: Equivocal
Female Mice: Equivocal
TR-153 Bioassay ofo-Toluidine
Hydrochloride for Possible Carcinogenicity
(CASNo. 636-21-5)
o-Toluidine and its hydrochloride salt are dye inter-
mediates used in the manufacture of a large number of
textile dyes which include some of the azo, tri-
arylmethane, sulfur, and indigoid compounds. In addi-
tion,therearenumeroussubstitutedo-toluidinesthatare
used asdyeintermediates.o-Toluidine alsofunctions as a
photographic dye, as a reagent in a clinical assay for
glucose and hemoglobin, and as an antioxidant in the
manufacture ofrubber.
A bioassay of o-toluidine hydrochloride for possible
carcinogenicitywas conducted byadministering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered o-toluidine hydrochloride at one of
several doses, either 3,000 or 6,000 ppm for rats and
either 1,000 or 3,000 ppm for the mice, for 101 to 104
weeks.Matchedcontrolsconsistedof20untreatedratsof
each sex and 20untreatedmice ofeach sex. All surviving
rats and mice were killed at the end ofadministration of
the test chemical.
Meanbodyweights ofdosed male and female rats and
mice were lower than those of corresponding matched
controls and were dose related. Mortalities of the male
and female rats were dose related and were relatively
high at the end of the bioassay. Mortalities of the male
andfemalemicewere not, however, significantly affected
by administration ofthe test chemical.
Inrats,theadministration ofthetestchemicalinduced
several types ofsarcomas ofthe spleen and otherorgans
in both males and females, mesotheliomas ofthe abdomi-
nal cavity or scrotum in males, and transitional-cell
carcinomas of the urinary bladder in females. Admin-
istration oftheo-toluidine hydrochloride also resulted in
increased incidences of fibromas of the subcutaneous
tissue in the males and fibroadenomas or adenomas of
the mammary gland in females.
In mice, hemangiosarcomas were induced at various
sites in males, and hepatocellular carcinomas or ade-
nomas were induced in females.
Under the conditions of this bioassay, o-toluidine
hydrochloride was carcinogenic in both male and female
F344 rats and B6C3F1 mice, producing a significant
increased incidence of one or more types of neoplasms.
Synonym: 2-aminotoluene hydrochloride
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Positive
Positive
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TR-154 Bioassay ofAzobenzene for
Possible Carcinogenicity (CAS No.
103-33-3)
Azobenzene occurs as a by-product during the man-
ufacture of benzidine. Benzidine is a widely used inter-
mediateforthe azo dyesandotherorganicchemicals and
is acarcinogen. Azobenzeneitselfhas noknown uses as a
dyestuff and is only produced in small quantities for
research purposes.
Abioassay ofazobenzene for possible carcinogenicity
was conductedbyadministeringthe testchemical infeed
to F344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered
azobenzene at oneoftwodoses, either200 or400 ppm,for
105 or106weeks. Matched controls consisted of20untre-
ated rats ofeach sex. All survivingrats were killed atthe
end of administration ofthe test chemical.
Groups of50malemice were administered azobenzene
at one oftwo doses, either200 or400 ppm, for 105weeks.
Groups of 50 female mice were administered the test
chemical at one oftwo doses, initially 400 or800 ppm, for
38weeks. Because ofexcessivelyloweredbodyweights in
the dosed groups of the females, doses for the females
were then reduced to 100 and 400 ppm, respectively, and
administration atthe lowered doses was continued for67
or 68 weeks. The time-weighted average doses for the
female mice were either 208 or 545 ppm. Matched con-
trols consisted of 20 untreated mice of each sex. All
survivingmice were killed atthe end ofadministration of
the test chemical.
Mean bodyweights ofdosed rats and mice ofeach sex
were lower than those of corresponding controls, and
were generally dose related throughout the bioassay.
Mortality was dose related in the male rats and the
female mice, but was not significantly affected in either
the female rats or the male mice. Survival was 70% or
greater at week 90 on study in all dosed and control
groups ofeach species and sex; thus, sufficient numbers
ofanimals were at risk in all groups for the development
oflate-appearing tumors.
In rats, a large number of sarcomas, including fibro-
sarcomas, hemangiosarcomas, and osteosarcomas in
both males and females and malignant hemangio-
pericytomas in females, occurred in the spleen and other
abdominal organs atincidences that were dose related in
each sex (P<0.001) and that in direct comparisons were
significantly higher(P<0.001)inthehigh-dose groups of
each sex than in the corresponding control groups
(males: controls, 0/20, low-dose 6/49, high-dose 31/49;
females: controls 0/20, low-dose 5/50, high-dose 21/50).
Inmice, no tumors occurredineithermales orfemales
at incidences that were significantly higher in the dosed
groups than in the corresponding control groups.
It is concluded that under the conditions of this bio-
assay, azobenzene was carcinogenic (sarcomagenic) for
F344 rats, inducing various types of sarcomas in the
spleen and other abdominal organs of both males and
females. The test chemical was not carcinogenic for
B6C3F1 mice of either sex.
Synonyms: diphenyldiimide; azobenzide
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Negative
TR-155 Bioassay of2,4,6-Trichlorophenol
for Possible Carcinogenicity (CAS No.
88-06-2)
2,4,6-Trichlorophenol is a germicidal agent that has
beenusedtopreservewoodandglueaswellastoprotect
textiles against mildew. Production ofthis chemical (for
sale as an end product)was discontinued in 1975 by Dow
Chemical Company, the only manufacturer of 2,4,6-
trichlorophenol in the United States, because ofthe high
costofremovingtoxicdioxinimpurities. However,asmall
quantity(2,204pounds)wasimportedfordomesticusein
1976.
A bioassay of 2,4,6-trichlorophenol for possible car-
cinogenicity was conducted by administering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of50 rats ofeach sexwere administered 2,4,6-
trichlorophenol atone oftwo doses, either5,000 or10,000
ppm, for 106 or107weeks. Matched controls consisted of
20 untreated rats of each sex. All surviving rats were
killed at the end of administration ofthe test chemical.
Groups of 50 male mice were administered 2,4,6-
trichlorophenol atone oftwodoses, either5,000 or10,000
for 105 weeks. Groups of 50 female mice were admin-
istered the test chemical at one of two doses, initially
either 10,000 or 20,000 ppm, for 38 weeks. Because of
excessively lowered bodyweights in the dosed groups of
thefemales, the dosesforthefemales werethen reduced
to 2,500 and 5,000 ppm, respectively, and administration
atthe lowerdoseswas continued for 67weeks. The time-
weighted average doses for the female mice were either
5,214 or 10,428 ppm. Matched controls consisted of 20
untreatedmiceofeachsex.Allsurvivingmicewerekilled
at the end ofadministration ofthe test chemical.
Meanbodyweights ofdosed rats and mice ofeach sex
were lower than those of corresponding controls and
were dose related throughout the bioassay. Survivals to
the end of the experiment were 68% or greater in all
groups ofrats and 80% or greater in all groups ofmice.
In the male rats, lymphomas orleukemias occurred at
incidencesthatweredoserelated(P=0.006)andindirect
comparisons were significantly higher in the low-dose
(P=0.019) and high-dose (P=0.004) groups than in the
corresponding control group (controls 4/20; low-dose
25/50;high-dose29/50). Leukocytosisandmonocytosisof
theperipheralbloodandhyperplasiaofthebonemarrow
also occurred in some dosed male rats not having lym-
phoma or leukemia.
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In female rats, monocytic leukemia did not occur at
incidences thatwere significant. However, as in the male
rats, leukocytosis and monocytosis of the peripheral
blood and hyperplasia of the bone marrow occurred in
the dosed female rats but not in the controls (blood
leukocytosis and monocytosis: controls 0/20, low-dose
6/50, high-dose 3/50; bone marrow hyperplasia: controls
0/20, low-dose 16/50, high-dose 2/50).
In both the male and female mice, hepatocellular car-
cinomas or adenomas occurred at incidences that were
dose related (P<0.001), and in direct comparisons were
significantly higher in the low- and high-dose male
groupsandthehigh-dosefemalegroup(P. 0.001) thanin
the corresponding control groups (males: controls 4/20,
low-dose 32/49, high-dose 39/47; females: controls 1/20,
low-dose 12/50, high-dose 24/48).
It is concluded that under the conditions of this bio-
assay, 2,4,6-trichlorophenol was carcinogenic in male
F344 rats, inducing lymphomas or leukemias. The test
chemical was also carcinogenic in both sexes ofB6C3F
mice, inducing hepatocellular carcinomas or adenomas.
Synonyms: Omal®; Dowicide® 2S
Report Date: 1979
Levels of Evidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
TR-156 Bioassay ofp,p'-Ethyl-DDD for
Possible Carcinogenicity (CAS No. 72-56-0)
p,p'-Ethyl-DDD, an organochlorine insecticide which
is marketed under the trade name Perthane®, has a
lower toxicity to both insects and mammals than its
structural analogs, DDT and DDD and is of moderate
persistence in the environment. First marketed in 1950
for use against houseflies and cloth moths, it has since
been used onvegetables, pears, and livestock. In the late
1950's, this compound was one of several DDT analogs
thatwere administered topatientswithbreast orprosta-
tic cancer for adrenocortical suppression because ofthe
selective toxicity of these compounds for the adrenal
cortex.
A bioassay of p,p'-ethyl-DDD for possible car-
cinogenicity was conducted by administering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered p,p'-
ethyl-DDD atone oftwodoses,either3,500 or7,000ppm,
for 105 weeks. Matched controls consisted of 20 untre-
ated rats ofeach sex. All survivingratswere killed atthe
end ofadministration ofthe test chemical.
Groups of 50 male mice were administered p,p'-ethyl-
DDD at one oftwo doses, either 2,500 or 5,000 ppm, for
105 weeks. Groups of50 female mice were administered
thetestchemical atone oftwodoses,initiallyeither5,000
or 10,000 ppm. Because of excessive lowered body
weights in the dosed groups offemales, the doses forthe
females were reduced after 48 weeks to 1,000 and 3,000
ppm, respectively, and administration at the lowered
doses was continued for 57 weeks. The time-weighted
average doses for the female mice were 2,828 and 6,200
ppm. Matched controls consisted of20 untreated mice of
each sex. All surviving mice were killed at the end of
administration ofthe test chemical.
Notumors occurredinthemale orfemalerats orinthe
male mice at incidences that could clearly be related to
administration ofthe test chemical.
In female mice, hepatocellular carcinomas or ade-
nomas occurred at incidences that were dose related
(P =0.011),butindirectcomparisons theincidencesinthe
individual dosed groups were not significantly higher
than that in the corresponding control group. Although
the occurrence of hepatocellular carcinomas or ade-
nomas in the dosed female mice are not clearlyrelated to
the administration of the test chemical, the increased
incidence of these tumors in the high-dose group sug-
gests that the tumors may be related to the administra-
tion ofp,p'-ethyl-DDD.
It is concluded that under the conditions of this bio-
assay, p,p'-ethyl-DDD was not carcinogenic for male or
female F344 rats or male B6C3F1 mice. However, the
occurrence of hepatocellular carcinomas and adenomas
in female mice was suggestive of a carcinogenic effect.
Synonym: 1,1-dichloro-2,2-bis(p-ethylphenyl)ethane
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Equivocal
TR-157 Bioassay ofMethyl Parathion for
Possible Carcinogenicity (CAS No.
298-00-0)
Methyl parathion is used in the agricultural industry
as a contact and stomach poison with broad-spectrum
insecticidal activity and someefficacyagainstmites. Itis
sold as a wettable power or emulsifiable concentrate for
foliage application. Several formulations contain com-
binations ofmethylparathion andethylparathion aswell
as other registered pesticides. There are 62 crops on
which methyl parathion is registered for use, but over
90% ofthe total volume used in 1974 was on cotton. It is
used to some extent in California for mosquito control.
A bioassay of methyl parathion for possible car-
cinogenicity was conducted by administering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered
methyl parathion at one oftwo doses, initially either 62.5
or 125 ppm. These doses were maintained for 102 weeks
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for the females; however, due to decreased mean body
weight gain in the dosed males, the low and high doses
for the males were reduced after 37 weeks to 20 and 50
ppm, respectively, and administration at the lowered
doses was continued for 65 weeks. The time-weighted
average doses for the male mice were 35 and 77 ppm,
respectively, for the low- and high-dose groups. Matched
controls consisted of 20 untreated mice of each sex. All
survivingmicewerekilled attheendofadministration of
the test chemical.
Mean bodyweights ofthe dosed male and female rats
and mice were lower than those of the corresponding
controls throughout the bioassay and were dose related.
Survival was unaffected in both species except for an
increase in mortality in the high-dose female rats, in
which 46% of the animals were alive at the end of the
study.
No tumors occurred in any of the groups of rats or
mice of either sex at incidences that were significantly
higher in the dosed groups than in the corresponding
control groups.
It is concluded that under the conditions of this bio-
assay, methyl parathion was not carcinogenic for F344
rats or B6C3F1 mice ofeither sex.
Synonym: 0,0-dimethyl 0(4-nitrophenyl)-phosphoro-
thioate
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-158 Bioassay of (2-Chloroethyl)
trimethylammonium Chloride (CCC) for
PossibleCarcinogenicity
(CAS No. 999-81-5)
(2-Chloroethyl)trimethylammonium chloride is aplant
growth regulator, ordwarfing agent, used onpoinsettias
and azaleas in the United States, and on several food
crops, specifically cereal grains, grapes, and pears in
Europe.
A bioassay of (2-chloroethyl)trimethylammonium
chloride for possible carcinogenicity was conducted by
administering the test chemical in feed to F344 rats and
B6C3F1 mice.
Groups of50 rats ofeach sex were administered either
1,500 or3,000 ppm ofthe compoundfor108weeks, and 50
mice ofeach sex were administered 500 or2,000 ppm for
102 weeks. Matched controls consisted of 20 untreated
and 20 untreated mice ofeach sex. All surviving animals
were killed at the end ofthe period ofadministration of
the test chemical.
Mean bodyweights ofdosed rats and mice were lower
thanthose ofcorresponding controlsforpartorallofthe
bioassay, except for the dosed male mice, whose mean
body weights were essentially the same as those ofthe
correspondingcontrols. Survivalwasnotaffectedsignifi-
cantlyin anyofthe dosed groups ofrats ormice andwas
at least 64% in every dosed or control group of each
species at the end ofthe bioassay. Sufficient numbers of
dosed and control rats and mice ofeach sexwere at risk
for the development of late-appearing tumors. Since
there was virtually no decrease in mean body weight in
dosed male mice and only a slight decrease in female
mice, and since there were no other toxic signs and no
dose-relatedmortality,theanimalsmayhavebeenableto
tolerate higher doses.
No tumors occurred in the rats ormice ofeither sex at
incidences that could be associated with administration
ofthe test chemical.
It is concluded that under the conditions of this bio-
assay, (2-chloroethyl)trimethylammonium chloride was
not carcinogenic for F344 rats or B6C3F1 mice ofeither
sex.
Synonyms: Cyclocel®; chlormequat; chlorocholine chlo-
ride; CCC
Report Date: 1979
Levels of Evidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-159 Bioassay ofPhthalic Anhydride
for Possible Carcinogenicity (CAS No.
85-44-9)
0
Phthalic anhydride is an important chemical inter-
mediate in the plastics industry. From it are derived
numerousphthalateestersthatfunctionasplasticizersin
synthetic resins. Phthalic anhydride itself is used as a
monomer for synthetic resins such as glyptal, the alkyd
resins, and the polyester resins. Phthalic anhydride is a
precursor of anthraquinone, phthalein, rhodamine, pht-
halocyanine, fluorescein, and xanthene dyes. Reaction of
phthalic anhydride with ammonia yields phthalimide, a
useful reagent in the synthesis of primary amines, the
agricultural fungicide phaltan, and thalidomide. Other
reactions yield phenolphthalein, benzoic acid, pht-
halylsulfathiazole (anintestinalantimicrobial agent),and
terephthalic acid.
A bioassay of phthalic anhydride for possible car-
cinogenicity was conducted by administering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered the
testchemical atoneoftwodoses,initiallyeither25,000 or
50,000 ppm, for 32 weeks. Because of excessive depres-
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sions in the amount ofbody weight gained in the dosed
groups, the doses for the males were then reduced to
12,500and25,000ppm,respectively, andthedosesforthe
females were reduced to 6,250 and 12,500 ppm. Admin-
istration of the test chemical at the lowered doses was
continued for 72 weeks. The time-weighted average
dosesforthemaleswereeither16,346 or32,692ppm,and
those for the females were either 12,019 or 24,038 ppm.
Matched controls consisted of20 untreated mice ofeach
sex. All surviving mice were killed at the end of the
period ofadministration ofthe test chemical.
Mean bodyweights ofthe high-dose male rats and of
the low- and high-dose mice ofeach sexwere lower than
those ofthe corresponding controls; mean bodyweights
ofthe low-dose male rats and ofboth the low- and high-
dose female rats were essentially unaffected by admin-
istration ofthe test chemical. Depressions in the amount
ofbodyweight gained in the male and female mice were
dose related throughout the bioassay. Survivals of the
rats and mice were not affected by administration ofthe
test chemical.
No tumors occurred inthe rats ormice ofeither sex at
incidencesthatcouldbeclearlyrelatedtotheadministra-
tion ofthe test chemical.
It is concluded that under the conditions of this bio-
assay, phthalic anhydride was not carcinogenic for F344
rats or B6C3F1 mice ofeither sex.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-160 Bioassay of2,4,5-Trimethylaniline
for Possible Carcinogenicity (CAS No.
137-17-7)
2,4,5-Trimethylaniline is a component of a mixture of
aromatic amines used in the synthesis of the red dye
Ponceau 3R. This dye is produced by diazotizing a mix-
ture of amine intermediates, some of which have been
identified asmethyl-,dimethyl-, ortrimethylanilines, and
coupling them with 2-naphthol-3,6-disulfonic acid. Pon-
ceau 3R is therefore a complex mixture containing some
1-(2,4,5-trimethylphenylazo)-2-naphthol-3,6-disulfonic
acid.
Ponceau 3R has been used as a color additive in foods
since 1907. It was certified as FD&C (Food Drug and
Cosmetic) Red No.1from1940until1960, atwhichtimeit
waswithdrawnfromgeneral use. Provisional recertifica-
tion asExt. D&C (ExternalDrugandCosmetic) Red No.
15 was granted shortly thereafter in 1961, but was
revoked in 1968.
A bioassay of 2,4,5-trimethylaniline for possible car-
cinogenicity was conducted by administering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered 2,4,5-trimethylaniline at one oftwo doses,
either 200 or 800 ppm for the rats and either 50 or 100
ppm for the mice, for 101 weeks. Matched controls con-
sisted of20untreated rats and 20untreatedmice ofeach
sex. All surviving animals were killed at the end of
administration ofthe test chemical.
Mean bodyweights ofthe dosed male and female rats
were generally lower than those of corresponding con-
trols; mean body weights of the dosed mice were only
slightly lower in the males than in the corresponding
controls and were unaffected or affected irregularly in
thefemales. Survivalwas notaffected significantlywhen
the rats ormicewere administered the testchemical and
was 70% or greater in all dosed or control groups.
Sufficient numbers of animals were at risk for late-
appearing tumors.
In the rats, hepatocellular carcinomas or neoplastic
nodules occurred atincidences that were dose related in
both males and females (P. 0.001), and in direct com-
parisons the incidences were slightly higher in the high-
dosemales,high-dosefemales, andlow-dosefemales(P<
0.004) than in corresponding controls (males: controls
1119; low-dose 6/50; high-dose 20/50; females: controls
0/20; low-dose 12/49, high-dose 27/50). In addition,
alveolar/bronchiolar carcinomas or adenomas occurred
in the female rats at incidences that were dose related
(P=0.003), and in a direct comparison the incidence was
significantly higher in the high-dose group (P= 0.017)
than in the corresponding control group (controls 0/20;
low-dose 3/43; high-dose 11/50).
In the female mice, hepatocellular carcinomas
occurred atincidences thatwere doserelated (PK 0.001),
and in direct comparisons the incidences were signifi-
cantly higher (P. 0.001) in the low- and high-dose ani-
mals than in the corresponding controls (controls 0/20,
low-dose 18/49, high-dose 40/50). Because historical
records ofthis laboratory for control B6C3F1 male mice
show a relatively high incidence of hepatocellular car-
cinomas, anincreased incidence ofthese tumors in 2,4,5-
trimethylaniline dosed male mice as compared with
matched controls could not be clearly associated with
administration ofthe test compound.
It is concluded that under the conditions of this bio-
assay, 2,4,5-trimethylaniline was carcinogenic for male
and female F344 rats and female B6C3F1 mice, inducing
hepatocellular carcinomas or neoplastic nodules in the
rats of each sex, alveolar/bronchiolar carcinomas in the
female rats, and hepatocellular carcinomas in female
mice.
Synonym: pseudocumidine
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Equivocal
Female Mice: Positive
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TR-161 Bioassay of Phthalamide for
Possible Carcinogenicity (CAS No. 88-96-0)
Phthalamide is recommended foruse as an accelerator
forcuringepoxyresins. Itisbelieved tobeused chieflyin
the paint industry.
Abioassayofphthalamide forpossible carcinogenicity
wasconductedbyadministeringthetestchemicalinfeed
to F344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered
phthalamide at one oftwo doses, either 15,000 or 30,000
ppm forthe males and either 5,000 or 10,000 ppmforthe
females, for106weeks. Groupsof50miceofeachsexwere
administered the test chemical at one of two doses,
25,000 or 50,000 ppm for the males, and at one of three
doses, 6,200, 12,500, or 25,000 ppm, for the females, for
103 or105weeks. Matched controls consisted of20untre-
ated rats of each sex, 20 untreated male mice, and two
groups of 20 untreated female mice. All surviving rats
and mice were killed at the end ofadministration ofthe
test chemical.
Mean body weights of the dosed groups of rats and
micewereeitherslightlylowerthanthoseofcorrespond-
ing control groups or essentially unaffected by admin-
istration of the test chemical. Also, survival was
unaffected in the rats and mice exceptforearlydeaths in
the high- and mid-dose groups of female mice. Survival
was 66% orgreater atthe end ofthebioassayin alldosed
groups and control groups ofeach species and sexexcept
for the high-dose group of female mice (36%). With the
exception of the high-dose female mice, sufficient num-
bers ofanimalswere atriskin all groupsforthe develop-
ment oflate-appearing tumors.
No tumors occurred in the rats ormice ofeither sex at
incidences that were significantly higher in the dosed
groups than in the corresponding control groups. How-
ever, phthalamide produced toxic lesions in the livers of
male and female rats and the urinary systems offemale
rats and mice. The presence of nonneoplastic lesions
suggests thatthe MTD mayhave been used orexceeded.
It is concluded that under the conditions of this bio-
assay, phthalamide was notcarcinogenic for F344 rats or
B6C3F1 mice ofeither sex.
Synonyms: o-phthalic acid diamide; P-D
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-162 Bioassay of 2,4-Diaminotoluene
for Possible Carcinogenicity (CAS No.
95-80-7)
2,4-Diaminotoluene is a widely used industrial inter-
mediate. Most of this chemical produced in the United
States is converted to toluene diisocyanate for use in the
synthesis ofpolyurethanes. 2,4-Diaminotoluene isalsoan
intermediate intheforthe synthesis ofdyes andusedfor
textiles, fur, leather, biological stains and indicators,
spiritvarnishes andwood stains, and pigments. In addi-
tion, it has been used as a component of oxidation-type
hair formulations. Two hundred and thirty-three million
pounds of 2,4-diaminotoluene were produced in the
United States in 1976. In addition, 356,000 pounds were
imported in that year.
Abioassay of2,4-diaminotoluene for possible carcino-
genicitywas conducted byadministeringthe test chemi-
cal in feed to F344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered 2,4-
diaminotoluene at one oftwo doses, initiallyeither125 or
250ppm,for40weeks.Becauseofexcessivedepressionin
the amount ofmean bodyweight gained in both low- and
high-dose groups, doseswere then reduced to 50 and 100
ppm, respectively. Administration of 50 ppm to the low-
dose groups was continued for 63 weeks, and surviving
animals in these groups were then killed. Surviving
animalsinthehigh-dosemalesandfemalesadministered
100 ppm were killed at the end of 39 and 44 weeks,
respectively, due to morbidity. The time-weighted aver-
age dose was 79 ppm for the low-dose male and females
for 103 weeks, 176 ppm for the high-dose males for 79
weeks, and 171 ppm for the high-dose females for 84
weeks.Matchedcontrolsconsistedof20untreatedrats of
each sex.
Groups of 50 mice ofeach sex were administered 2,4-
diaminotoluene atoneoftwodoses, either100or200ppm,
for101weeks. Matchedcontrols consistedof20untreated
mice ofeach sex. Survivingmicewere killed atthe end of
administration ofthe test chemical.
Meanbodyweights ofdosedmale and female rats and
mice were lower than those of corresponding controls
andwere dose related except forthe low-dose malemice,
for which mean body weights were only slightly lower
than those ofcontrols. Mortality was not dose related in
either the male or female mice, but was dose related in
both the male and female rats. Survival was decreased
and lesions ofhepatonephrotoxicitywere observed inthe
animals administered the 2,4-diaminotoluene.
In the rats, hepatocellular carcinomas or neoplastic
nodules occurred at incidences thatwere dose related in
both the males (P=0.014) and the females (P=0.008). In
direct comparisons ofincidences ofthe tumors in control
and dosed groups, the incidence in the high-dose male
group had a P value of 0.026 (males: controls 0/20, low-
dose 5/49, high-dose 10/50; females: controls 0/20; low-
dose 0/50, high-dose 6/49). The significance ofthe occur-
rence of these tumors in both the male and female rats
was supported by the high incidences ofassociated non-
neoplastic lesions ofthe liver in the dosed groups and by
low incidences of liver tumors in historical-control male
or female F344 rats at the same laboratory.
In addition, carcinomas or adenomas ofthe mammary
gland occurred in the female rats atincidences thatwere
dose related (P =0.002) and in direct comparisons were
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higherin the dosed groups (P<0.001) than in the control
group (control 1120; low-dose 38/50, high-dose 41V50).
In male rats, fibromas of the subcutaneous tissue
occurred atincidences thatwere doserelated (P=0.004)
and in direct comparisons were higher in the dosed
groups (P. 0.020) than in the control group (controls
0/20, low-dose 15/30, high-dose 19/50).
Inthemice,hepatocellular carcinomas occurredinthe
females at incidences that were dose related (P=0.002)
and in direct comparisons were higher in dosed groups
(P. 0.007) than in the control group (controls 0/19, low-
dose 13/47, high-dose 18/46). In addition, lymphomas
occurred at a significant incidence (P<0.001) in the low-
dose female mice (controls 2/19, low-dose 29/47, high-
dose 11/46). No tumors occurred at significantly
increased incidences in the dosed male mice.
Under the conditions of this bioassay, 2,4-
diaminotoluene was carcinogenic for F344 rats, inducing
hepatocellular carcinomas or neoplastic nodules in both
males and females and carcinomas or adenomas of the
mammary gland in females. The test chemical was also
carcinogenic for female B6C3F1 mice, inducing
hepatocellular carcinomas. The incidence oflymphomas
inthefemalemice suggested thatthesetumors mayalso
have been related to administration ofthe test chemical.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Positive
TR-163 Bioassay ofCalcium Cyanamide
for Possible Carcinogenicity (CAS No.
156-62-7)
Calcium cyanamide was first synthesized in 1898 and
became one ofthe earliest successes in nitrogen fixation.
The commercially formulated product contains approx-
imately 65% calcium cyanamide, which is 20 to 24%
nitrogen. For most ofthe 20th century it has been used
as a fertilizer, and also as a cotton defoliant, herbicide,
and soilinsecticide. Its use as afertilizer has diminished
in recent years due to the introduction of other com-
pounds, so that the chief industrial uses of calcium
cyanamide today stem from the reactivity ofthe nitrile
group. Calcium cyanamide can be dimerized to dicyan-
diamide, an intermediate for melamine, one ofthe basic
ingredients in amino plastics and resins. Other products
preparedfromcalciumcyanamideincludeurea,thiourea,
andguanidine. Fusionofcalciumcyanamidewith sodium
chloride produces calcium cyanide, which is required for
oreprocessing and theproduction offerrocyanides. Cal-
cium cyanamide is added to pig iron to impart nitrogen
and to remove sulfur from steel.
A bioassay of formulated calcium cyanamide for
possiblecarcinogenicitywasconductedbyadministering
the test chemical in feed to F344 rats and B6C3Fj
mice.
Groups of 50 rats of each sex were administered a
commercial formulation containing 63% calcium
cyanamide in the diet at one of two doses, either 100 or
200 ppm for the males and either 100 or 400 ppm for the
females,for107weeks.Groupsof50miceofeachsexwere
administered thetestchemicalatoneoftwodoses,either
500 or 2,000 ppm, for 100 weeks. Matched controls con-
sisted of20untreated rats and20untreatedmice ofeach
sex. All surviving animals were killed at the end of
administration ofthe test chemical.
Mean body weights of the dosed rats and mice were
onlyslightlylowerthanthose ofcorrespondingcontrols,
except for the low-dose female mice, whose mean body
weights were unaffected by the test chemical. Mortality
was dose related onlyin male mice. Survival was 70% or
greater in all dosed and control groups of each species
and sexattheendofthebioassay, andsufficientnumbers
ofanimals were at risk in all groups for the development
oflate-appearing tumors. Both rats and mice may have
been able to tolerate higher doses.
No tumors occurred in the dosed rats ofeither sex at
incidences thatcould clearlyberelated to administration
of the calcium cyanamide. However, in the subchronic
studies performed with the rats, calcium cyanamide was
found to cause diffuse follicular hyperplasia of the thy-
roid,withperiglandularfibrosis andprominentperiglan-
dularvascularity.
In male mice, hemangiosarcomas were dose related in
the males (P=0.006); however, in direct comparisons,
incidences in theindividual dosed groupswerenotsignif-
icantly higher than those in the control group (controls
1120 (5%); low-dose 2/50 (4%); high-dose 10/50 (20%)).
The incidence ofthese tumors in historical-control male
B6C3F1 mice was (13/323 (4%)), and the highest inci-
dence observed was 2/19 (10%). In female mice, lym-
phomasorleukemiasweredoserelated(P=0.009),andin
a direct comparison the incidence ofthese tumors in the
high-dose group was significantly higher (P=0.006)
than that in the control group (controls 1/20 (5%); low-
dose 11/46 (24%); high-dose 18/50 (36%)); however, the
incidence of the lymphomas or leukemias in historical-
control female B6C3F1 mice was 67/324 (21%), suggest-
ing that the incidence of these tumors in the matched-
control group of the present bioassay may have been
abnormally low. Thus, neither the incidences of
hemangiosarcomas of the circulatory system in male
mice nor oflymphomas or leukemias in the female mice
can clearly be related to administration of the test
chemical.
It is concluded that under the conditions of this bio-
assay, the testformulation ofcalcium cyanamidewas not
carcinogenic for F344 rats or B6C3F1 mice of either
sex.
Synonyms: cyanamide; CaNCN
Report Date: 1979
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Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-164 Bioassay of
N-Nitrosodiphenylamine for Possible
Carcinogenicity (CAS No. 86-30-6)
N-Nitrosodiphenylamine is a nitrosoamine which is
used as avulcanization retarderincuringnaturalrubber
and the synthetic elastomers styrenebutadiene and
nitrile-butadiene. U.S. production in 1976 was 1.3 million
pounds.
A bioassay of N-nitrosodiphenylamine for possible
carcinogenicity was conducted byadministering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered
N-nitrosodiphenylamine at one oftwo doses, either1,000
or 4,000 ppm, for 100 weeks. Matched controls consisted
of20 untreated rats ofeach sex. All surviving rats were
killed at the end of administration of the test chemical.
Groups of 50 male mice were administered N-nitro-
sodiphenylamine at one of two doses, either 10,000 or
20,000 ppm,for101weeks. Groups of50femalemice were
administered the test chemical at one of two doses,
initially 5,000 or 10,000 ppm, for 38 weeks. Because of
excessive depression in the amount ofmean bodyweight
gained in the dosed groups, the doses for the females
were then reduced to 1,000 and 4,000 ppm, respectively,
and administration at the lowered doses was continued
for 60 weeks. The time-weighted average doses for the
female mice were either 2,315 or 5,741 ppm. Matched
controls consisted of 20 untreated mice of each sex. All
survivingmice werekilled attheend ofadministration of
the test chemical.
Mean bodyweights ofdosed rats and mice ofeach sex
were lower than those of corresponding controls, and
were dose related throughout the bioassay, except for
those offemale rats duringthe firstpart ofthe bioassay.
Mortality was doserelatedinthefemalerats,butwasnot
affected when the test chemical was administered to the
male rats or the male orfemale mice. Survival atthe end
of the bioassay was 64% or greater in the dosed and
control groups ofrats andmice ofeach sex, and sufficient
numbers of animals were at risk in all groups for the
development oflate-appearing tumors.
Transitional-cell carcinomas of the urinary bladder
occurred at incidences that were dose related (P. 0.001)
in both male and female rats, and in direct comparisons
theincidences ofthese tumors inthehigh-dose groups of
each sex were significantlyhigher (PK 0.001) than those
in the corresponding controls (males: controls 0/19; low-
dose 0/46; high-dose 16/45; females: controls 0/18; low-
dose 0/48; high-dose 40/49). The possible mechanism by
which these tumors were induced, such as calculi forma-
tion in the bladder or nitrosation of amines present in
feed to a carcinogenic nitrosoamine, is unknown.
Fibromas of the integumentary system occurred in
malerats atincidencesthatweredoserelated (P=0.003),
although in direct comparisons the incidences of these
tumors in the individual dosed groups were not signifi-
cantly higher than those in the control group (controls
1120, or 5%; low-dose 1150, or 2%; high-dose 10/50, or
20%). The incidence of fibromas of the integumentary
system in historical-control male F344 rats at this labo-
ratoryis 6/285, or2%. These results suggest an associa-
tion of the fibromas in the male rats with the
administration ofthe test chemical.
No tumors occurred in the mice of either sex at inci-
dencesthatweresignificantlyhigherinthedosedgroups
than in the corresponding control groups. The only
changes related to compound administration were
chronic inflammatory lesions in the urinary bladders of
dosed mice.
It is concluded that under the conditions of this bio-
assay, N-nitrosodiphenylamine was carcinogenic for
both sexes of F344 rats, including transitional-cell car-
cinomas ofthe urinarybladder, butwas not carcinogenic
for B6C3F1 mice ofeither sex.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Negative
TR-165 Bioassay of 4-Chloro-o-toluidine
Hydrochloride for Possible Carcinogenicity
(CAS No. 3156-93-3)
4-Chloro-o-toluidine hydrochloride is used commer-
cially as an intermediate for dyestuffs intended for tex-
tiles, e.g.,pigmentyellow49andpigmentred 7, aswell as
C.I, 12800, azoic coupling component 8, and azoic diazo
component 11.
A bioassay of 4-chloro-o-toluidine hydrochloride for
possible carcinogenicity was conducted by administer-
ing the test chemical in feed to F344 rats and B6C3Fj
mice.
Groups of 50 rats of each sex were administered
4-chloro-o-toluidine inthe diet at one oftwo doses, either
1,250 or 5,000 ppm, for 107 weeks. Groups of 50 mice of
each sexwere administered the test chemical in the diet
at one of two doses, either 3,750 or 15,000 ppm for the
males and either 1,250 or 5,000 ppm for females, for 99
weeks, except for the high dose females (92 weeks).
Matched controls consisted of 20 untreated rats and 20
untreated mice of each sex. All surviving animals were
killed at the end of administration of the test chemical.
Mean bodyweights ofthe high-dose rats and the low-
and high-dose mice ofeach sexwere lower than those of
corresponding controls, and those ofthe mice were dose
related. Mortality was not significantly affected by
administration ofthe test chemical to rats ofeither sex
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andsurvivalwas75% orgreaterattheendofthestudyin
dosed and control groups. Sufficient numbers of rats
were at risk for the development of late-appearing
tumors. In mice, mortalitywas dose related foreach sex.
In rats no tumors occurred at incidences which could
clearly be related to administration ofthe test chemical.
In both male and female mice, hemangiosarcomas
occurred atincidences thatwere doserelated (P 0.001),
andindirectcomparisonstheincidences inthehigh-dose
males and the low- and high-dose females were signifi-
cantlyhigher (P<0.001) than thosein the corresponding
controls (males: controls 0/20; low-dose 3/50; high-dose
37/50; females: controls 0/18; low-dose 40/49, high-dose
39/50). The combined incidences of hemangiosarcomas
andhemangiomasalsoweredoserelatedandweresignif-
icantly higher in the dosed groups of male and female
mice than in the corresponding controls. There was a
highincidenceofhemosiderindepositintherenaltubular
epithelium, particularlyinmicewithhemangiosarcomas.
It is concluded that under the conditions of this bio-
assay, 4-chloro-o-toluidine hydrochloride was not car-
cinogenic forF344 ratsbutwas carcinogenic forB6C3F1
mice, including hemangiosarcomas and hemangiomas in
both males and females.
Synonym: 2-amino-4-chlorotoluene hydrochloride
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Positive
Positive
untreated mice of each sex. All surviving animals were
killed at the ends ofthe periods ofadministration ofthe
test chemical.
Meanbodyweights ofthe dosed rats and mice ofeach
sexwere lowerthanthose ofcorresponding controls and
were dose related throughout most ofthe bioassay. Mor-
talitywas not significantlyaffected byadministration of
the testchemicaltoeithertherats ofthemice, exceptfor
the female rats, inwhich the mortalitywas higherin the
control group than in the dosed groups; however, the
survival atthe end ofthebioassaywas 65% or greaterin
all dosed and control groups of rats and mice of either
sex, and sufficient numbers of animals were at risk in
eachgroupforthedevelopmentoflate-appearingtumors.
No tumors occurred inthe rats ormice ofeither sex at
incidencesthatweresignificantlyhigherindosedgroups
than in corresponding control groups.
It is concluded that under the conditions of this bio-
assay, tetraethylthiuram disulfide was not carcinogenic
for F344 rats or B6C3F1 mice ofeither sex.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-167 N-Butylurea (CAS: 592-31-4)
Sodium Nitrite (CAS: 7632-00-0)
Dataconsidered tobeinconclusive andnotreportable; no
Technical Report issued.
TR-166 Bioassay ofTetraethylthiuram
Disulfide for Possible Carcinogenicity
(CASNo.97-77-9)
Tetraethylthiuram disulfide is known in the rubber
industry as ethyl tuads where it is used in compounding
naturalrubberandthesynthetic elastomersisobutylene-
isoprene, butadiene, styrene-butadiene, isoprene, and
nitrile-butadiene rubber. It is used both as a rubber
accelerator and vulcanizing agent, as an activator of
thiazole accelerators, and as a plasticizer in neoprene.
Current estimates indicate that 510,000 to 550,000 kilo-
grams ofchemical are produced annually worldwide.
A bioassay of technical-grade tetraethylthiuram dis-
ulfide for possible carcinogenicity was conducted by
administering the test chemical in feed to F344 rats and
B6C3F1 mice.
Groups of 50 rats of each sex were administered
tetraethylthiuram disulfide in the diet at one of two
doses, either300 or 600ppm, for107weeks. Groups of50
mice ofeach sex were administered the test chemical at
one of two doses, either 500 or 2,000 ppm for the males
and either 100 or 500 ppm for the females, for 108weeks.
Matched controls consisted of20 untreated rats and 20
TR-168 Bioassay ofN-(1-Naphthyl)
ethylenediamine Dihydrochloride for
Possible Carcinogenicity (CAS No.
1465-25-4)
N-(1-Naphthyl)ethylenediamine dihydrochloride, a
diagnostic reagent derived from 1-naphthylamine, was
selected for bioassay by the National Cancer Institute
because of the suspected carcinogenicity of its parent
compound, and the confirmed bladder carcinogenicity of
the related compound 2-naphthylamine in humans.
A bioassay for the possible carcinogenicity of N-(1-
naphthyl)ethylenediamine dihydrochloride was con-
ducted using Fischer 344 rats and B6C3F1 mice. N-(1-
Naphthyl)ethylenediamine dihydrochloride was admin-
istered in the feed, at either of two concentrations, to
groups of50male and 50female animals ofeach species.
Twenty-five rats ofeach sexand 50mice ofeach sexwere
placed on test as controls. The high and low dietary
concentrations of N-(1-naphthyl)ethylenediamine
dihydrochloride administered toratsandmalemicewere
0.1 and 0.05percent,respectively. Thehighand lowtime-
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weighted average concentrations administered to female
mice were, respectively, 0.3 and0.2 percent. The compound
was administered in the diet for 104 weeks, followed by an
observation period of4 weeks for high dose rats, 3 weeks
for low dose rats, low dose female mice, and high dose
female mice, and 1 week for high dose male mice.
There were no significant positive associations
between the concentrations of N-(1-naphthyl) eth-
ylenediamine dihydrochloride administered and mor-
tality in rats of either sex or in male mice. There was a
significant positive association between concentration
and mortality in female mice. In all groups, except for
high dose females, adequate numbers of animals sur-
vived sufficiently long to be at risk from late-developing
tumors. Mean body weight depression, in relation to
controls, was apparent for both sexes of rats and mice,
indicatingthathigherconcentrations ofthetestchemical
would not have been tolerated by these animals.
Inrats ormice ofeither sex, there were no statistically
significant positive associations between the concentra-
tion of N-(1-naphthyl)ethylenediamine dihydrochloride
and tumor incidence.
Under the conditions ofthis bioassay, dietary admin-
istration ofN-(1-naphthyl)ethylenediamine dihydrochlo-
ride was not carcinogenic in Fischer 344 rats orB6C3Fj
mice.
Synonyms: N-1-Naphthalenyl-1,2-ethanediamine dihy-
drochloride; N-1-Naphthylethylenediamine dihydro-
chloride
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-169 Bioassay of 2-Nitro-
p-phenylenediamine for Possible
Carcinogenicity (CAS No. 5307-14-2)
2-Nitro-p-phenylenediamine. a component of both
semipermanent and permanent hair dye formulations,
was selected for bioassay by the National Cancer
Institute because of the increased incidence of bladder
cancer amongdyemanufacturingindustryworkers.Aro-
matic amines are one ofseveral classes oforganic chemi-
cals thought to contribute to the increased cancerriskin
this industry. The widespread exposure to 2-nitro-
p-phenylenediamine among the general population, and
the possibility of an increased cancer risk among hair-
dressers were additional factors in the selection of this
compound for testing.
A bioassay for the possible carcinogenicity of2-nitro-
p-phenylenediamine was conducted using Fischer 344
rats and B6C3F1 mice. 2-Nitro-p-phenylenediamine was
administered in the feed, at either oftwo concentrations,
to groups of 50 male and 50 female animals of each
species. Twenty animals of each sex and species were
placed on test as controls. The high and low dietary
concentrations of 2-nitro-p-phenylenediamine were,
respectively, 1,100 and 550 ppm for male rats, 2,200 and
1,100 ppm for female rats, and 4,400 and 2,200 ppm for
mice ofboth sexes. The compound was administered in
thedietfor78weeks,followedbyanobservationperiodof
27 weeks for rats and 12 to 13 weeks for mice.
There were no significant positive associations
between the dietary concentrations of 2-nitro-
p-phenylenediamine administered and mortality in rats
and mice ofeither sex. Adequate numbers ofanimals in
all groups survived sufficiently long to be at risk from
late-developing tumors. Mean body weight depression,
relative to controls, was observed in dosed rats and mice
ofboth sexes, indicating that the concentrations admin-
istered to these animals may have approximated the
maximum tolerated dosages.
When the female mice in each group, having
hepatocellular carcinoma or hepatocellular adenoma,
were combined and the resulting incidences statistically
analyzed, there was a significant positive association
betweenconcentration administered and theincidence of
thesetumors.Thisfindingwassupportedbyasigniflcant
high dose to control Fischer exact comparison. No
tumors occurred in statistically significant increased
incidences when dosed male or female rats or male mice
were compared to their respective controls.
Under the conditions of this bioassay, dietary admin-
istration of 2-nitro-p-phenylenediamine was carcino-
genic to female B6C3F1 mice, causing an increased
incidence of hepatocellular neoplasms, primarily
hepatocellular adenomas. There was no convincing evi-
denceforthe carcinogenicity ofthe compoundin Fischer
344 rats or in male B6C3F1 mice.
Synonyms: 2-Nitro-1,4-benzenediamine; Diaminonitro-
benzene; m-Nitro-p-phenylenediamine; o-Nitro-
p-phenylenediamine; 2-Nitro-1,4-diaminobenzene; 1,4-
Diamino-2-nitrobenzene; 2-NP; 2-NPPD; 2-N-p-PDA;
Ursol Brown RR; Zoba Brown RR; Fourrine Brown 2R;
Fourrine 36; Fouramine 2R; C.I. Oxidation Base 22
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Positive
TR-170 Bioassay of a Solution of
,B-Nitrostyrene and Styrene for Possible
Carcinogenicity (CAS No. 102-96-5, CAS
No.100-42-5)
3-Nitrostyrene was selected for bioassay by the
National Cancer Institute because of a lack ofadequate
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carcinogenicity data. The compound is usually supplied
as a 30 percent solution in styrene and this commercial
product was selected as the material to be tested.
13-Nitrostyrene is used as a chain stopper in styrene
typepolymerization reactions forthe production ofpoly-
styrene plastics, synthetic rubber, and resins.
P-Nitrostyrene also possesses antibacterial, antifungal,
andinsecticidal activities andhasbeensuggestedforuse
as a repellent for bats and other rodents; however, this
compound does notappeartobe currentlyregisteredfor
pesticide use with the U.S. Environmental Protection
Agency.
A bioassay of a solution of 30 percent 3-nitrostyrene
and 70 percent styrene for possible carcinogenicity was
conducted usingFischer344 rats and B6C3F1 mice. The
solution ofthe two test materials in corn oil was admin-
istered by gavage, at either oftwo dosages, to groups of
50 male and 50 female animals ofeach species. The high
and low dosages utilized in the studywere, respectively,
300 and 150 mg/kg for male rats; 150 and 75 mg/kg for
female rats; and 175 and 87.5 mg/kg for mice of both
sexes. These dosages are expressed in terms of the
3-nitrostyrene contained inthe styrene solution. Twenty
animals of each species and sex were placed on test as
controls, and were gavaged with corn oil on the same
schedule as dosed animals.
A 79-week period ofchemical administration was fol-
lowedbyanadditionalobservationperiodof29weeksfor
rats, and a 78-week period of chemical administration
wasfollowedbyanadditional14-weekobservationperiod
for mice.
There was no significant difference between the sur-
vival ofrats dosedwith the test solution andthatoftheir
controls, and there was no significant association
betweendosageandmortalityamongfemalemice.There
was a significant positive association between dosage
andmortalityamongmalemice;however, adequate num-
bers ofanimals in all groups survived sufficientlylongto
be at risk from late-developing tumors. There was dis-
tinct mean body weight depression when high dose
femalemiceormaleratswerecomparedtotheircontrols,
indicatingthatthe dosage administered tothese animals
may have approximated the maximum tolerated dosage.
Since nodistinctmeanbodyweightdepression, nosignif-
icantly accelerated mortality, and no other toxic effects
were associated with the administration of B-nitrosty-
reneandstyrenetofemaleratsormalemice,itispossible
that these animals may have been able to tolerate a
higher dosage.
There were no significant positive associations
between administration of the solution and increased
tumor incidence in rats ofeither sex.
When those male mice having either alveolar/
bronchiolar carcinomas or alveolar/bronchiolar adenoma
were combined and the resulting tumor incidences for
each group were statistically analyzed, the low dose to
control Fischer exact comparison was significant. The
Cochran-Armitage test and the high dose to control
comparison,however,werenot. Noothertestsfortumors
ofanysiteineithermale orfemalemiceweresignificant.
Under the conditions of this bioassay, there was no
convincing evidence for the carcinogenicity ofa solution
of ,B-nitrostyrene and styrene in Fischer 344 rats or in
B6C3F1 mice.
Synonymsfor 3-Nitrostyrene: (2-Nitroethenyl)benzene;
w-Nitrostyrene; BNS
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-171 Bioassay of2,4-Dimethoxyaniline
Hydrochloride for Possible Carcinogenicity
(CASNo. 54150-69-5)
2,4-Dimethoxyaniline hydrochloride, the hydro-
chloride salt of the dye intermediate 2,4-
dimethoxyaniline, was selected for bioassay by the
National Cancer Institute because ofthe increased inci-
dence of bladder cancer among dye manufacturing
industry workers. Aromatic amines are one of several
classes of chemicals thought to contribute to the
increased cancer risk in this industry.
A bioassay for the possible carcinogenicity of 2,4-
dimethoxyaniline HCl was conducted using Fischer 344
rats and B6C3F1 mice. 2,4-Dimethoxyaniline HCl was
administered inthefeed, ateither oftwo concentrations,
to groups of 50 male and 50 female animals of each
species. Twenty animals of each sex and species were
placed on test as controls. The high and low dietary
concentrations of 2,4-dimethoxyaniline HCl were,
respectively, 3,000 and 1,500 ppm for rats and 5,000 and
2,500 ppm for mice. The compound was administered in
the diet for 104 weeks to rats and 103 weeks to mice,
followedbya1-week observationperiod forboth species.
There were no significant positive associations
between the concentrations of2,4-dimethoxyaniline HCl
administered and mortality in rats or mice ofeither sex.
Adequate numbers of animals in all groups survived
sufficiently long to be at risk from late-developing
tumors. Dose-related mean bodyweight depression was
observed for females ofboth species, indicating that the
concentrations of 2,4-dimethoxyaniline HCl admin-
istered to these groups may have approximated the
maximum tolerated concentrations. Compound-related
mean body weight depression was only slight for male
rats and was apparent in male mice only until week 50;
howeverfollicular-cell hyperplasias and cystic follicles of
the thyroid were observed in dosed male mice, suggest-
ing that the concentrations the male mice received may
have approximated the maximum tolerated concentra-
tions. Since no distinct mean body weight depression in
relation to controls, no significant accelerated mortality,
and no other signs of toxicity were associated with
97NTP/NIEHS
administration of2,4-dimethoxyaniline HCl to male rats,
it is possible that these animals may have been able to
tolerate a higher dietary concentration.
There was a significant positive trend between con-
centration of the test chemical and the incidence of a
combination ofhepatocellular carcinomas and adenomas
in male mice and an increase in the combination ofthese
lesions in female mice. However, no statistically signifi-
cant differences in tumor incidence at any site were
observed when dosed rats and mice were compared to
their respective controls.
Under the conditions of this bioassay there was no
convincing evidence for the carcinogenicity of 2,4-
dimethoxyaniline HCl in Fischer 344 rats or B6C3Fj
mice.
Synonyms: 2,4-dimethoxybenzenamine hydrochloride;
4-methoxy-o-anisidine hydrochloride; 2-methoxy-
p-anisidine hydrochloride
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-172 Bioassay of Sodium
Diethyldithiocarbamate for Possible
Carcinogenicity (CAS No. 148-18-5)
Sodium diethyldithiocarbamate is a chelating agent
used primarilyin the analytical determination of copper,
arsenic, nickel, and other metals. Other applications
include the detection oftoxic metals in urine, and in the
treatment ofhuman poisoning with metals.
A bioassay of sodium diethyldithiocarbamate for
possiblecarcinogenicitywasconductedbyadministering
the test chemical in feed to F344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex were administered sodium
diethyldithiocarbamate at one oftwo doses, either1,250 or
2,500 ppm, for 104 weeks. Groups of 50 mice of each sex
were administered sodium diethyldithiocarbamate at one
oftwo doses, either500 or4,000 ppm, for108 or109weeks.
Matched controls consisted of 16 untreated male rats, 20
untreatedfemaleratsand20untreatedmiceofeach sex.All
surviving rats and mice were killed at the end of admin-
istration ofthe test chemical.
Mean body weights of all dosed groups of rats and
mice werelowerthatthose ofcorrespondingcontrols and
were dose related throughout the bioassay except those
of the low-dose male rats, which were essentially
unaffected by administration of the test chemical. Sur-
vivals ofthe rat and mice were unaffected, and no other
clinical signs could be related to administration of the
test chemical; thus, the animals may have been able to
tolerate higher doses. Sufficient numbers of dosed and
control animals ofeach species and sex were at risk for
the development oflate-appearing tumors.
No tumors occurred in the rats ormice ofeither sex at
incidences that were significantly higher in the dosed
groups than in the control groups.
It is concluded that under the conditions of this bio-
assay, sodium diethyldithiocarbamate was not carcino-
genic for F344 rats or B6C3F1 mice ofeither sex.
Report Date: 1979
Levels ofEvidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-173 Bioassay ofCarbromal for
Possible Carcinogenicity (CAS No. 77-65-6)
Carbromal, amild central nervous systemdepressant,
was selected for bioassay by the National Cancer
Institute because of the similarity of the biological
activity of this compound to that of urethan, which is
known to induce leukemia in mice and is an initiator of
skin carcinogenesis in mice, and the widespread expo-
sure to this compound among the general population via
deliberate ingestion formedicinal purposes.
A bioassay for the possible carcinogenicity ofcarbro-
mal was conducted using Fischer 344 rats and B6C3F1
mice. Carbromal was administered in the feed, at either
oftwoconcentrations, to groupsof50maleand 50female
animals ofeach species with the exception of49 lowdose
male mice and high dose female mice. Twenty animals of
each sexand specieswereplaced on test as controls. The
high and low dietary concentrations of carbromal were,
respectively, 2,500 and 1,250 ppm for rats and 2,500 and
1,250 ppm for mice. The compound was administered for
103weeks to rats and for 78weeks to mice. Theperiod of
compoundadministrationwasfollowedbyanobservation
period of1 week for rats and 26 weeks for mice.
Therewas nosignificantpositiveassociationsbetween
the concentrations of carbromal administered and mor-
talityin rats or mice ofeither sex. Adequate numbers of
animals in all groups survived sufficiently long to be at
risk from late-developing tumors. Slight dose-related
meanbodyweightdepressionwasobservedformalerats
andforfemalesofbothspeciesandthemeanbodyweight
amongdosed male micewas lowerthanthatforcontrols,
indicating that the concentrations of carbromal admin-
istered to the animals in this bioassaymayhave approxi-
mated the maximum tolerated concentrations.
Noneofthe statistical tests foranysiteinfemale rats or
inmiceofeithersexindicated asignificantpositiveassocia-
tion between compound administration and tumor inci-
dence.Therewas asignificantpositiveassociationbetween
the concentrations administered and the incidences of
adrenal pheochromocytomas in male rats; however, the
Fischer exact comparisons were not significant.
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Under the conditions ofthis bioassay, dietary admin-
istration of carbromal was not carcinogenic in Fischer
344 rats or B6C3F1 mice.
Synonyms: N-(aminocarbonyl)-2-bromo-2-ethyl-bu-
tanamide; (2-bromo-2-ethylbutyryl)urea, bromodiethyl-
acetylcarbamide; bromodiethylacetylurea; (a-bromo-ot-
ethylbutyryl)carbamide
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-174 Bioassay ofp-Phenylenediamine
Dihydrochloride for Possible
Carcinogenicity (CAS No. 624-18-0)
p-Phenylenediamine dihydrochloride, a hydrochloride
salt of p-phenylenediamine, the major component of
many oxidation hair dyes, was selected for bioassay by
the National Cancer Institute because of the increased
incidence of bladder cancer reported among dye man-
ufacturingindustryworkers.Aromatic amines are oneof
several classes ofchemicals thoughtto contribute to this
increased cancer risk. The widespread exposure to
p-phenylenediamine among the general population and
theincreased cancerriskamonghairdresserswere addi-
tional factors in the selection of p-phenylenediamine
dihydrochloride for testing.
Abioassay ofp-phenylenediamine dihydrochloride for
possible carcinogenicity was conducted using Fischer
344 rats and B6C3F1 mice. p-Phenylenediamine
dihydrochloridewasadministeredinthefeed, ateitherof
two concentrations, to groups of 50 male and 50 female
animals ofeach species. Thehigh and lowconcentrations
of p-phenylenediamine dihydrochloride were, respec-
tively, 1,250 and 625 ppm for both rats and mice. After a
103-weekperiod ofcompound administration, therewere
additional observation periods of2 weeks for rats and 1
week for mice. Twenty animals of each sex and species
were placed on test as controls.
There were no significant positive associations
between the concentrations of p-phenylenediamine
dihydrochloride administered and mortality in rats or
mice of either sex. Adequate numbers of animals in all
groups survived sufficiently long to be at risk from late
developing tumors. Slight dose-related mean body
weight depression was observed in female rats and the
meanbodyweights amonghighdosemalerats anddosed
female mice were slightly depressed in relation to their
respective controls, indicating that the concentrations of
p-phenylenediamine dihydrochloride administered to
these animals in this bioassay may have approximated
the maximum tolerated concentrations. Since no distinct
mean body weight depression relative to controls, no
significant accelerated mortality, and no other signs of
toxicity were associated with administration of p-phe-
nylenediamine dihydrochloride to male mice, it is
possible that these animals may have been able to toler-
ate a higher dietary concentration.
None ofthe statistical testsforanysite in rats ormice
of either sex, including time to leukemia or malignant
lymphomaanalysisinfemalemice,indicated asignificant
positive association between compound administration
and tumor incidence.
Under the conditions of this bioassay, there was no
convincingevidencethatdietaryadministrationofp-phe-
nylenediamine dihydrochloride was carcinogenic in
Fischer 344 rats or B6C3F1 mice.
Synonyms: 1,4-benzenediamine dihydrochloride; p-PDA
HCl; p-OD HCl; p-phenylenediamine di-HCl; Durafur
Black RC; Fourrine DS; Fourrine 64; Pelagol Grey CD;
C.I. Oxidation Base 10A
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-175 Bioassay ofLithocholic Acid for
Possible Carcinogenicity (CAS No.
434-13-9)
Lithocholic acid, a naturally occurring bile acid, was
selected for bioassay by the National Cancer Institute
becauseithasbeenreported topromote the development
of hepatoma and hyperplastic nodules induced by DL-
ethionine in rat liver, and because ofthe strong correla-
tion between concentrations of neutral sterols and bile
acid derivatives in human feces and the incidence of
human colon cancer.
A bioassay for the possible carcinogenicity of
lithocholicacidwasconductedusingFischer344ratsand
B6C3F1 mice. Lithocholic acid was administered by
gavage, ateitheroftwodosages,togroupsof50maleand
50 female animals ofeach species, except for 49 low dose
female rats. Twentyanimals ofeach sexand specieswere
placed on test as controls. The high and low dosages of
lithocholic acid administered were, respectively, 500 and
250 mg/kgfor rats and 250 and 125 mg/kg for mice. The
compound was administered to rats and mice for 103
weeks. The period of compound administration was fol-
lowed by an observation period of 1 week for rats and 2
weeks for mice.
There were no significant positive associations
betweenthedosages oflithocholic acid administered and
mortalityinrats ormiceofeithersex.Adequatenumbers
ofanimalsinallgroups survivedsufficientlylongtobe at
risk from late-developing tumors. Slight dose-related
mean bodyweight depression was observed in male rats
99NTP/NIEHS
and female mice and high incidences of chronic kidney
inflammation were observed in female rats, indicating
thatthe dosages oflithocholic acid administered tothese
animals in this bioassay may have approximated the
maximum tolerated dosages. Since no meanbodyweight
depression, relativetocontrols, nosignificant accelerated
mortality, and no other signs oftoxicitywere associated
with administration oflithocholic acid to male mice, it is
possible that these animals may have been able to toler-
ate a higher dosage. However, in the subchronic study
there were deaths among all dosed male mouse groups,
eventhosereceivinglithocholic acidatalevelonlytwofold
greater than the high dose utilized in the chronic study.
None of the statistical tests for any site in rats or in
mice ofeither sexindicated asignificantpositive associa-
tion between compound administration and tumor inci-
dence.
Under the conditions of this bioassay, lithocholic acid
was not carcinogenic when administered by gavage to
Fischer 344 rats or B6C3F1 mice.
Synonyms: (3ao,53)-3-Hydroxycholan-24-oic acid; 3ox-
Hydroxy-53-cholan-24-oic acid; 3ox-Hydroxy-53-cholanic
acid; 3o-Hydroxychloanic acid; 3-Monohydroxycholanic
acid; 173-(1-methyl-3-carboxypropyl)ethiocholan-3o-ol.
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-176 N,N-Dimethyl-P-Nitrosoaniline
(CAS: 138-89-6)
Data considered to be inconclusive and notreportable;
no Technical Report issued.
TR-177 Bioassay of 4'-(Chloroacetyl)-
acetanilide for Possible Carcinogenicity
(CAS No. 140-49-8)
4'-(Chloroacetyl)-acetanilide, an intermediate in the
synthesis of dyes and pharmaceutical compounds, was
selected for bioassay by the National Cancer Institute
because of the increased incidence of bladder cancer
observed among dye manufacturing industry workers.
Aromatic amines, such as 4'-(chloroacetyl)-acetanilide,
are among several classes of chemicals thought to con-
tribute to the increased cancer risk in this industry, and
4'-(chloroacetyl)-acetanilide is especially suspect
because it is structurally similar to the possible human
renal pelvic carcinogen, phenacetin.
A bioassay for the possible carcinogenicity of
4'-(chloroacetyl)-acetanilide was conducted using
Fischer 344 rats and B6C3F1 mice. 4'-(Chloroacetyl)-
acetanilide was administered inthe feed, ateither oftwo
concentrations, to groups of 50 male and 50 female
animals ofeach species. Twenty animals ofeach sex and
specieswere placed on test as controls. The high and low
dietary concentrations of 4'-(chloroacetyl)-acetanilide
were, respectively, 2,000 and 1,000 ppm for rats and
10,000and5,000ppmformice.Thecompoundwasadmin-
istered for 87weeks ofa 102-week period in rats and for
90weeks ofa105-weekperiodinmice. Micewerekilled at
the end of the last week of compound administration,
while rats were observed for 1 week after compound
administration ceased.
There were no significant positive associations
between the concentration of 4'-(chloroacetyl)-
acetanilide administered and mortalityin rats ormice of
either sex. Adequate numbers of animals in all groups
survived sufficiently long to be at risk from late-
developing tumors. Dose-related mean body weight
depression was observed for males and females ofboth
species, indicating that the concentrations of
4'-(chloroacetyl)-acetanilide administered to the animals
in this bioassay may have approximated the maximum
tolerated concentrations.
Noneofthestatisticaltestsforanysiteinratsofeither
sex or in male mice indicated a significant positive asso-
ciation between compound administration and tumor
incidence.Although therewas a significantpositive asso-
ciation between the concentration of the compound
administered and the incidences of hepatocellular ade-
nomas in female mice, the Fischer exact comparisons
were not significant.
Under the conditions of this bioassay, 4'-
(chloroacetyl)-acetanilide was not carcinogenic when
administered in the diet to Fischer 344 rats or B6C3Fj
mice ofeither sex.
Synonyms: N'-(Chloroacetyl)-N-phenylacetamide;
4-(Cl-acetyl)acetanilide
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-178 Bioassay of 2-(Chloromethyl)
pyridine Hydrochloride for Possible
Carcinogenicity (CAS No. 6959-47-3)
2-(Chloromethyl)pyridine hydrochloride, an aromatic
heterocycle used in a variety of syntheses, was selected
forbioassaybythe National Cancer Institute because of
the structural similarity of this compound to 2-(x,4-
dichloroethyl)-pyridine hydrochloride, a carcinogen in
rats, mice, Syrian hamsters, and Mongolian gerbils.
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Abioassay for the possible carcinogenicity of2-(chlo-
romethyl)pyridine hydrochloride was conducted using
Fischer 344 rats and B6C3F1 mice. 2-(Chlo-
romethyl)pyridine hydrochloride was administered by
gavage, ateitheroftwodosages, togroupsof50maleand
50 female animals of each species, with the exception of
49 male rats in the high dose group. Twenty animals of
each sex and species were placed on test as vehicle
controls. The high and low dosages of 2-(chlo-
romethyl)pyridine hydrochloride administered were,
respectively, 150 and 75 mg/kg for rats and 250 and 125
mg/kg for mice. The compound was administered for 99
weeks to rats and mice. The period ofcompound admin-
istration was followed by an observation period of 6
weeks for rats and 5 weeks for mice.
There were no significant positive associations
between the dosages of2-(chloromethyl)pyridine hydro-
chloride administered and mortality in rats or mice of
either sex. Adequate numbers of animals in all groups
survived sufficiently long to be at risk from late-
developing tumors. Slight dose-related mean body
weight depression was observed in mice of both sexes,
indicating that the dosages of 2-(chloromethyl)pyridine
hydrochloride administered to these animals in this bio-
assaymayhave approximatedthemaximumtolerated con-
centrations. Sincenodistinctmeanbodyweightdepression
relative to vehicle controls, no significant accelerated mor-
tality, and no other signs oftoxicity were associated with
administration of2-(chloromethyl) pyridine hydrochloride
torats, itispossiblethatthese animalsmayhavebeen able
to tolerate a higher dosage.
None ofthe statistical tests for any site in female rats
or in mice of either sex indicated a significant positive
association between compound administration and
tumor incidence. There was a significant positive trend
between the dosages administered and the incidences of
subcutaneous fibromas in male rats. The Fischer exact
comparisons, however, were not significant.
Under the conditions of this bioassay, administration
of 2-(chloromethyl)pyridine hydrochloride was not car-
cinogenic to Fischer 344 rats or B6C3F1 mice.
Synonyms: 2-(Cl-methyl)pyridine HCl; 2-pyridylmethyl
chloride hydrochloride; 2-picolyl chloride hydrochloride
Report Date: 1979
Levels of Evidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-179 Bioassay ofp-Quinone Dioxime
for Possible Carcinogenicity (CAS No.
105-11-3)
p-Quinone dioxime, arubbervulcanization accelerator,
was selected for bioassay by the National Cancer
Institute because of a lack of adequate carcinogenicity
data.
A bioassay for the possible carcinogenicity of
p-quinone dioximewas conductedusing Fischer344 rats
and B6C3F1 mice. p-Quinone dioxime was administered
in the feed, at either oftwo concentrations, to groups of
50 male and 50 female animals of each species. Twenty
animals of each sex and species were placed on test as
controls, with the exception of 18 in the control male
mouse group. The high and low concentrations of
p-quinone dioxime were 750 and 375 ppm for rats and
1,500 and 750 ppm for mice. The compound was admin-
istered to rats and mice for 104 weeks. The period of
compoundadministrationwasfollowedbyanobservation
period of1week for both species.
There were no significant positive associations
between the concentrations ofp-quinone dioxime admin-
istered and mortality in rat& or mice of either sex.
Adequate numbers of animals in all groups survived
sufficiently long to be at risk from late-developing
tumors. Distinct dose-related meanbodyweight depres-
sion was observed among rats and slight mean body
weight depression, relative to controls, was observed
among mice, indicating that the dosages of p-quinone
dioximeadministered totheanimalsinthisbioassaymay
have approximated the maximum tolerated concentra-
tions.
Thmors ofthe urinary bladder were observed only in
dosed rats. For female rats, there was a significant
positive association between concentration administered
and the incidences of a combination of urinary bladder
neoplasms. The high dose to control Fischer exact com-
parison was also significant for these tumors in female
rats. No compound-related neoplasms were observed in
male rats or mice ofeither sex.
Under the conditions ofthis bioassay, dietary admin-
istrationofp-quinonedioximewascarcinogenic tofemale
Fischer344 rats, causing neoplasms ofthe urinaryblad-
der.The compoundwas notcarcinogenic tomale Fischer
344 rats or B6C3F1 mice ofeither sex.
Synonyms: 2,5-cyclohexadiene-1,4-dione; dioxime p-ben-
zoquinone; p-quinonedioxime; dioxime 1,4-cyclohexa-
dienedione
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Positive
Male Mice: Negative
Female Mice: Negative
TR-180 Bioassay of4-Nitro-
o-phenylenediamine for Possible
Carcinogenicity (CAS No. 99-56-9)
4-Nitro-o-phenylenediamine, a component of both
semipermanent and permanent hair dye formulations,
10112TP/NIEHS
was selected for bioassay by the National Cancer
Institute because ofthe highincidence ofbladder cancer
reported among workers in the dye manufacturing
industry.
A bioassay for the possible carcinogenicity of4-nitro-
o-phenylenediamine was conducted using Fischer 344
rats and B6C3F1 mice. 4-Nitro-o-phenylenediamine was
administered in thefeed, ateitheroftwo concentrations,
to groups of 50 male and 50 female animals of each
species. Twenty animals of each sex and species were
placed on test as controls. The high and low dietary
concentrations of 4-nitro-o-phenylenediamine were,
respectively, 750 and375ppmforrats and 7500 and3750
ppm for mice. The compound was administered for 103
weeks to rats and for 102 weeks to mice. The period of
compoundadministrationwasfollowedbyanobservation
period of2 weeks for rats and mice.
There were no significant positive associations
between the concentrations of 4-nitro-o-phenylene-
diamine administered and mortality in rats or mice of
either sex. Adequate numbers of animals in all groups
survived sufficiently long to be at risk from late-
developing tumors. Distinct dose-related mean body
weight depression was observed in mice, indicating that
the concentrations of 4-nitro-o-phenylenediamine
administered to these animals in this bioassay mayhave
approximated the maximum tolerated concentrations.
Since nodistinctmeanbodyweightdepressionrelativeto
controls, no significantly accelerated mortality, and no
other manifestations ofchronic toxicity were associated
with administration of 4-nitro-o-phenylenediamine to
male or female rats, it is possible that these animals
may have been able to tolerate a higher dietary
concentration.
None of the statistical tests for any site in rats or in
mice ofeither sexindicated asignificantpositive associa-
tion between compound administration and tumor inci-
dence.
Under the conditions ofthis bioassay, dietary admin-
istration of4-nitro-o-phenylenediamine was not carcino-
geinic in Fischer 344 rats or B6C3F1 mice.
Synonyms: 4-nitro-1,2-benzenediamine; 4-nitro-
phenylenediamine; 4-nitro-1,2-diaminobenzene; 1,2-
diamino-4-nitrobenzene; 2-amino-4-nitroaniline; 4-NO;
4-NOP; 4-NOPD; 4-N-o-PDA; C.I. 76020
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
National Cancer Institute because of the elevated inci-
dence ofbladdercancernoted amongdyemanufacturing
industry workers.
A bioassay for the possible carcinogenicity of
technical-grade Michler's ketone was conducted using
Fischer344 rats and B6C3F1 mice. Michler's ketonewas
administered in thefeed, ateither oftwo concentrations,
to groups of 50 male and 50 female animals of each
species. Twenty animals of each sex and species were
placed on test as controls. The high and low dietary
concentrations ofMichler's ketonewere respectively, 500
and 250 ppm formale rats, 1,000 and 500 ppm for female
rats, and 2,500 and 1,250ppm formice ofboth sexes. The
compound was administered to rats and mice for 78
weeks. The period of compound administration was fol-
lowedby an observation period of28weeks formale and
high dose female rats, 29weeks for low dose female rats
and 13 weeks for mice.
There were significant positive associations between
the concentrations ofMichler's ketone administered and
mortality in rats and mice ofboth sexes. Adequate num-
bers ofanimals in all groups survived sufficientlylongto
be at risk from late-developing tumors. There was dis-
tinct dose-related mean body weight depression in
female rats and inmice ofboth sexes, and the mean body
weight among dosed male rats was slightly lower than
that in controls, indicating that the concentrations of
Michler's ketone administered to these animals in this
bioassaymayhaveapproximatedthemaximumtolerated
concentrations. X
There were significant positive associations between
the concentrations ofMichler's ketone administered and
theincidences ofhepatocellular carcinomasinboth sexes
ofratsandinfemalemiceandhemangiosarcomasinmale
mice. In all of these cases the high dose to control
Fischer exact comparison was also significant.
Under the conditions ofthis bioassay, dietary admin-
istration of Michler's ketone was carcinogenic to male
and female Fischer 344 rats and female B6C3F1 mice,
causing hepatocellular carcinomas, and to male B6C3Fj
mice, causing hemangiosarcomas.
Synonyms: bis[4-(dimethylamino)phenyl]methanone;
4,4'-bis(dimethylamino)benzophenone; p,p'-bis (dimethy-
lamino)benzophenone; bis[p-(N,N'-dimethylamino) phe-
nyl]ketone; tetramethyldiaminobenzophenone
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
TR-181 Bioassay ofMichler's Ketone for
Possible Carcinogenicity (CAS No. 90-94-8)
Michler's ketone, a dye intermediate and derivative of
dimethylaniline, was selected for bioassay by the
Positive
Positive
Positive
Positive
TR-182 Acetamide (CAS: 60-35-5)
Data considered tobeinconclusive and notreportable;
no Technical Report issued.
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TR-183 Bioassay ofDibutyltin Diacetate
for Possible Carcinogenicity (CAS No.
1067-33-0)
Dibutyltin diacetate, a widely used catalyst for poly-
merization reactions, was selected for bioassay by the
National CancerInstituteinanefforttoscreenanumber
oforgano-metallic compounds for carcinogenicity.
Abioassay for the possible carcinogenicity ofdibutyltin
diacetate was conducted using Fischer 344 rats and
B6C3F1 mice.Dibutyltindiacetatewasadministeredinthe
feed, at either oftwo concentrations, to groups of50 male
andfemaleanimalsofeachspecies.Twentyanimalsofeach
sex and species were placed on test as controls. The high
and low time-weighted average dietary concentrations of
dibutyltindiacetatewere,respectively, 133and66.5ppmfor
rats and 152 and 76 ppm for mice. The compound was
administered for 78 weeks to rats and mice, followed by a
period ofno compound administration of26weeks forrats
and 14 weeks for mice.
There were significant positive associations between
the concentrations of dibutyltin diacetate administered
and mortality in male rats and female mice. There were
no significant positive associations between the con-
centrations administered and mortalityin female rats or
male mice. Adequate numbers of animals in all groups
survived sufficiently long to be at risk from late-
developing tumors. Mean body weight depression, rela-
tive to controls, was observed in male mice and signifi-
cantly accelerated mortality, relative to controls, was
observed in male rats and female mice, indicating that
the concentrations of dibutyltin diacetate administered
to these animals may have approximated the maximum
tolerated concentrations. Since no mean body weight
depression, nosignificantlyacceleratedmortality, andno
other signs oftoxicity were associated with administra-
tion ofdibutyltin acetate tofemalerats, itispossible that
these animals may have been able to tolerate a higher
dietary concentration.
There were no neoplasms occurring in statistically
significant higher incidences in dosed rats or mice when
compared to their respective controls. However, there
was an accidental loss oftissues from high dose female
rats which precluded an evaluation ofcarcinogenicity in
this group of animals. There was a significant positive
association between the concentrations administered
andtheincidences ofhepatocellular adenomasinfemales
mice; however, the Fischer exact comparisons were not
significant using the Bonferroni criterion. Liver neo-
plasms (i.e., a combination ofadenomas and carcinomas)
werealsoobservedinmalemice;however,theoccurrence
was not statistically significant.
Under the conditions of this bioassay, there was no
conclusive evidence for the carcinogenicity of dibutyltin
diacetateinmaleFischer344ratsorB6C3F1 miceofeither
sex. Theloss oftissues takenfromhigh dosefemale ratsin
thisbioassayprecluded anevaluationofthecarcinogenicity
ofdibutyltin diacetate to female Fischer 344 rats.
Synonyms: bis(acetyloxy)dibutylstannae; diacetox-
ydibutylstannae; diacetoxybutyltin; dibutyl tin diacetate
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Inadequate Study
Male Mice: Negative
Female Mice: Negative
TR-184 Bioassay ofNitrofen for Possible
Carcinogenicity (CAS No. 1836-75-5)
Nitrofen, asubstituteddiphenylether,is oneofseveral
agricultural pesticides selected for bioassay by the
National Cancer Institute because of a lack of carcino-
genicity data.
Abioassay for thepossible carcinogenicity ofnitrofen
was conducted using Fischer344 rats and B6C3F1 mice.
Nitrofen was administered in the feed, at either of two
concentrations, to groups of 50 male and 50 female
animals ofeach species. Twenty animals ofeach sex and
species wereplaced on test as controls. Thehigh and low
dietary concentrations of nitrofen were 6000 and 3000
ppmforbothspecies. Thecompoundwasadministered to
rats and mice for 78 weeks, followed by a period of no
compound administration of 26 weeks for rats and 13
weeks for mice.
There were no significant positive associations
between theconcentrations ofnitrofenadministered and
mortalityinrats ormiceofeither sex.Adequatenumbers
ofanimalsin allgroups survived sufficientlylongtobe at
risk from late-developing tumors. Dose-related mean
body weight depression, relative to controls, was
observed for males and females ofboth species, indicat-
ing that the concentrations of nitrofen administered to
the animals in this bioassay may have approximated the
maximum tolerated concentrations.
Noneofthestatistical testsforanysiteinratsofeither
sex indicated a significant positive association between
compound administration and tumor incidence. There
was a significant positive association between the con-
centration ofnitrofen administered and theincidences of
hepatocellular carcinomas in mice ofboth sexes.
In another bioassay of nitrofen for possible carcino-
genicity, the compound was found to induce hepatocellu-
lar carcinomas in B6C3F1 mice of both sexes and
hemangiosarcomas ofthe liver in male B6C3F1 mice. In
addition, adenocarcinomas ofthepancreas were induced
in female Osbourne-Mendel rats.
Under the conditions ofthis bioassay, dietary admin-
istration of nitrofen was carcinogenic to B6C3F1 mice,
causing hepatocellular carcinomas in both sexes. There
was no evidence for carcinogenicity in Fischer 344 rats.
Synonyms: 2,4-dichloro-1-(4-nitrophenoxy)-benzene, 2,4-
dichlorophenyl-p-nitrophenyl ether, nitrophene, Tok
E-25, Nip
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Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
Note: Nitrofen waspreviouslystudiedbyadministration
in feed to Osborne-Mendel rats and B6C3F1 mice (See
TR-26, reported 1979).
TR-185 Bioassay of Styrene for Possible
Carcinogenicity (CAS No. 100-42-5)
Styrene, a widely used intermediate in the manufac-
ture ofplastics, elastomers, and resins, was selected for
bioassaybythe National Cancer Institutebecause ofthe
widespread use ofthis compound and a lack ofadequate
carcinogenicity data.
Abioassayfor the possible carcinogenicity ofstyrene
was conducted using Fischer344 rats and B6C3F1 mice.
Styrene was administered by gavage to groups of 50
maleand50femaleanimals ofeachspecies. Fortyrats of
each sex and twentymice ofeach sex wereplaced on test
asvehiclecontrols.Thehigh,medium, andlowdosages of
styrene administered to rats were, respectively, 2,000,
1,000, and 500 mg/kg. The high and low dosages admin-
isteredtomice were300and150mg/kg,respectively. The
compound was administered for 78 weeks to high and
medium doserats, for103weeks tolowdoserats, andfor
78 weeks to mice. The period of compound administra-
tion was followed by an observation period of27 weeks
forhigh and medium dose rats, 1week for low dose rats,
and 13weeks formice.
Mortality among male and female high dose rats was
significantly higher than that among their respective
vehicle controls. In response to this elevated and early
mortality, an additional dosed group of each sex was
included in the chronic bioassay. No significant positive
association was apparent between dosage and mortality
among anyotherdosedrat groups. Formice, there was a
significant positive association between mortality and
the dosages ofstyrene administered to males, but not to
females. Adequate numbers of animals in all groups,
except for the high dose male and female rats, survived
sufficiently long to be at risk from late-developing
tumors. Slight dose-related mean body weight depres-
sion was apparentwhen male rats and female mice were
compared to their respective vehicle controls, indicating
that the dosages administered to these animals during
the chronic bioassay may have approximated the max-
imum tolerated dosages. There was no distinct depres-
sion in mean body weight when dosed female rats and
dosed male mice were compared to their respective
vehicle controls. However, since there was significant
accelerated mortality among high dose female rats, it is
possible that the dosage administered to the medium
dose female rats mayhave exceeded the maximum toler-
ated dosage.
In male mice, there was a significantpositive associa-
tion between styrene dosage and the incidences of a
combination of adenomas and carcinomas of the lung.
This finding was supported by the high dose to control
Fischer exact comparison. However, the variation ofthe
incidence of these neoplasms in historical control male
mice atthis laboratorydoes notpermitafirm conclusion
of carcinogenicity. There was no significant difference
between tumor incidence at any other site in male mice,
or at any site in rats or female mice, when dosed groups
were compared to vehicle controls.
Thefindingsofanincreasedincidenceofacombination
of adenomas and carcinomas of the lung provided sug-
gestive evidence for the carcinogenicity of styrene in
male B6C3F1 mice. However, it is concluded that, under
theconditionsofthisbioassay,noconvincingevidencefor
the carcinogenicity of the compound was obtained in
Fischer 344 rats or B6C3F1 mice ofeither sex.
Synonyms: ethenylbenzene; vinylbenzene; vinylbenzol;
styrolene; styrol; styrole; styropol; styropor; styron;
cinnamene; cinnamol; phenethylene; phenylethylene;
phenylethene
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Equivocal
Female Mice: Negative
TR-186 Bioassay of4,4'-Methylenebis-
(N,N-dimethyl)benzeneamine for Possible
Carcinogenicity (CAS No.101-61-1)
4,4'-Methylenebis(N,N-dimethyl)benzeneamine, a
bicyclic aromatic amine and an intermediate in dye man-
ufacture, was selected forbioassaybythe National Can-
cer Institute because of a high incidence of bladder
cancer observed among dye manufacturing industry
workers.
A bioassay for the possible carcinogenicity of 4,4'-
methylenebis-(N,N-dimethyl)benzeneamine was con-
ducted using Fischer 344 rats and B6C3F1 mice.
4,4'-Methylenebis-(N,N-dimethyl)benzeneamine was
administered in thefeed, ateitheroftwo concentrations,
to groups of 50 male and 50 female animals of each
species. Twenty animals of each sex and species were
placed on test as controls. The high and low dietary
concentrations of4,4'-methylenebis-(N,N-dimethyl) ben-
zeneamine were, respectively, 750 and 375 ppm for rats
and 2500 and 1250 ppm for mice. The compound was
administered for 59 weeks to rats and for 78 weeks to
mice. The period of compound administration was fol-
lowed by an observation period of45 weeks for rats and
13 weeks for mice.
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There were no significantly positive associations
between the concentrations of 4,4'-methylenebis-(N,N-
dimethyl)benzeneamine administered and mortality
among rats or mice of either sex. Adequate numbers of
animals survived sufficientlylongtobe atriskfromlate-
developing tumors. There was slight dose-related mean
body weight depression among female rats, the mean
bodyweightofhighdosemaleratswasslightlylessthan
that for controls, and the mean body weights of dosed
miceweresignificantlylowerthantheircontrols,indicat-
ing that the concentrations of 4,4'-methylenebis-(N,N-
dimethyl)benzeneamine administered to these animals
in this bioassay may have approximated the maximum
tolerated concentrations.
Forboth male andfemale rats, therewas a significant
positive association between the concentrations of 4,4'-
methylenebis-(N,N-dimethyl)benzeneamine admin-
istered and the incidences offollicular-cell carcinomas of
the thyroid (i.e., V18, 4/50, and 21146 in the control, low
dose, and high dose males, respectively; and 0/20, 3/46,
and23/45inthecontrol, lowdose, andhigh dosefemales,
respectively). The high dose to control Fischer exact
comparisons were also significant for each sex.
Liver neoplasms were observed among male and
female mice. There were elevated incidences of
hepatocellular adenomas in dosed mice when compared
to controls (i.e., 2/20, 3/50, and 16/48 in control, low dose,
and high dose males, respectively; and 1/19, 18/49, and
22/48 in control, low dose, and high dose females). The
incidencesofhepatocellularcarcinomasindosedmicedid
not differ greatly from those in controls (i.e., 3/20, 9/50,
and 6/48 in control, low dose, and high dose males,
respectively; and 0/19, 149, and 1148 in control, low dose,
and high dose females). Amongboth sexes ofmice, there
was a significant positive association between the con-
centrations of the chemical administered and the inci-
dences ofa combination ofhepatocellular adenomas and
hepatocellular carcinomas. For male mice, the Fischer
exact comparisons were not significant; however, for
females,boththehigh doseto controlandthelowdoseto
control comparisons were significant.
In both sexes ofboth species nonneoplastic prolifera-
tive lesions ofthe thyroid occurred in dosed animals but
not in any ofthe controls.
Under the conditions of this bioassay, 4,4'-
methylenebis-(N,N-dimethyl)benzeneamine was car-
cinogenic in Fischer 344 rats, inducing thyroid follicular-
cell carcinomas in both males and females. Administra-
tion of the compound was carcinogenic in female
B6C3F1 mice, inducing liver neoplasms. There was no
conclusive evidence that 4,4'-methylenebis-(N,N-di-
methyl)benzeneaminewas carcinogenic inmaleB6C3Fj
mice.
Synonyms: 4,4'-methylenebis(N,N-dimethyl)aniline;
tetramethyldiaminodiphenylmethane; 4,4'-bis(dime-
thylamino) diphenylmethane; Tetrabase; Methanebase;
Michler's base; Michler's hydride; Michler's methane
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Equivocal
Positive
TR-187 Bioassay of 5-Chloro-o-toluidine
for Possible Carcinogenicity (CAS No.
95-79-4)
5-Chloro-o-toluidine, an aromatic amine and dyeinter-
mediate, was selected for bioassayby the National Can-
cer Institute because of the high incidence of bladder
cancer observed among dye manufacturing industry
workers.
Abioassayforthepossiblecarcinogenicityof5-chloro-
o-toluidine was conducted using Fischer 344 rats and
B6C3F1 mice. 5-Chloro-o-toluidine was administered in
the feed, at either oftwo concentrations, to groups of50
male and 50 female animals of each species. Twenty
animals of each sex and species were placed on test as
controls. The high and low dietary concentrations of
5-chloro-o-toluidine were 5,000 and 2,500 ppm for rats
and 4,000 and 2,000 ppm for mice. The compound was
administered in the diet for 78 weeks, followed by an
observation period of26 weeks for rats and 13weeks for
mice.
There were significant positive associations between
the concentrations of 5-chloro-o-toluidine administered
and mortality among male and female mice, but not
amongratsofeithersex.Adequatenumbersofanimalsin
all groups survived sufficiently long to be at risk from
late-developing tumors. Distinct mean body weight
depression was apparent when dosed female rats and
dosedmiceofboth sexeswerecomparedtotheircontrols,
indicating thatthe concentrations administered to these
animals in this bioassay may have approximated the
maximum tolerated concentrations. Since no mean body
weight depression, relative to controls, no significantly
accelerated mortality, and no signs oftoxicity otherthan
fatty metamorphosis of the liver were associated with
administration of 5-chloro-o-toluidine to male rats, it is
possible that these animals may have been able to toler-
ate a higher dietary concentration ofthe compound.
There was a significant positive association between
the concentration of5-chloro-o-toluidine administered to
male rats and the incidence of adrenal phe-
ochromocytomas in these animals; however, neither of
the Fischer comparisons was significant. None of the
other statistical tests for tumors at any site in male and
female rats indicated a significant positive association
between dosage and incidence.
In mice of both sexes there were significant positive
associations between concentration administered and
theincidence ofhemangiosarcomas. Inaddition, thehigh
dose to control Fischer exact comparisons forboth sexes
were significant. The Cochran-Armitage tests were also
significant and positive for theincidences ofhepatocellu-
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lar carcinomas in both sexes of mice. For males and
females the high dose to control Fischer exact com-
parisonswere significant, andforfemalesthelowdoseto
control comparison was also significant.
Under the conditions of this bioassay, 5-chloro-
o-toluidine was carcinogenic to B6C3F1 mice, inducing
hemangiosarcomas and hepatocellular carcinomas in
both males and females. There was no conclusive evi-
dence ofthe carcinogenicity ofthe compound in Fischer
344 rats.
Synonyms: 5-chloro-2-methylbenzeneamine; p-chloro-
o-aminotoluene; 4-chloro-2-aminotoluene; 2-amino-4-
chlorotoluene; o-amino-p-chlorotoluene; 5-chloro-2-
methylaniline; 2-methyl-5-chloroaniline; 1-amino-2-
methyl-5-chlorobenzene; 1-amino-3-chloro-6-methyl-
benzene; Fast Red KB Base; Azogene Fast Red KB;
Brentamine Fast Red KB Base; Naphthosol Fast Red
Base; Naphthanil Red KB Base
Report Date: 1979
Levels ofEvidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
TR-188 Sodium Iodomethanesulfonate
(CAS: 126-31-8)
Data considered tobeinconclusive and notreportable;
no Technical Report issued.
TR-189 Bioassay ofp-Chloroaniline for
Possible Carcinogenicity (CAS No.
106-47-8)
p-Chloroaniline, a dye and chemical intermediate, was
selected for bioassay by the National Cancer Institute
because ofthehigh incidence ofbladder cancer observed
among dye manufacturing industry workers.
A bioassay for the possible carcinogenicity ofp-chlo-
roaniline was conducted using Fischer 344 rats and
B6C3F1 mice. p-Chloroaniline was administered in the
feed, ateitheroftwoconcentrations, to groups of50male
and 50female animals ofeach species. Twentyanimals of
each sex and specieswereplaced on test as controls. The
high and low dietary concentrations of p-chloroaniline
were,respectively, 500and250ppmforrats and5000and
2500 ppm for mice. The compound was administered in
thedietfor78weeks,followedbyanobservationperiodof
24 weeks for rats and 13 weeks for mice.
There were no significant positive associations
between the dietary concentrations of p-chloroaniline
administered and mortality in female rats or in mice of
either sex; however, there was a significantly positive
association between concentration andmortalityin male
rats.Adequatenumbers ofanimalsinallgroups survived
sufficiently long to be at risk from late-developing
tumors. Mean body weight depression, in relation to
controls, was observed in high dose female rats and
dosed mice ofboth sexes, indicating that the concentra-
tion of p-chloroaniline administered to these animals
may have approximated the maximum tolerated con-
centrations. Although splenic lesions were observed in
male rats, no mean body weight depression relative to
controls was associated with administration of p-chlo-
roaniline to these animals. Therefore, it is possible that
these animals may have been able to tolerate a higher
dietary concentration ofthe compound.
The onlyneoplastic lesionsfoundthatmightbe related
to administration of the compound were mesenchymal
tumors in the spleens ofmale rats and hemangiomatous
tumors in mice. In male rats, there was a significant
positive association between compound administration
and the incidences of fibroma or fibrosarcoma of the
spleen. The incidences of these tumors were not signifi-
cantly elevated when compared to those in control rats,
but the rarity of these tumors in male Fischer 344 rats
(0/360 in historical male control rats in this laboratory)
stronglysuggests achemicallyrelatedeffect. Inaddition,
three sarcomas of other types were found in high dose
male rats. In mice of both sexes, hemangiomas and
hemangiosarcomas were found at elevated incidences,
when compared to control mice, in the spleen, liver,
kidney, andmultiple body sites. Theincreased incidences
in dosed mice were statistically related to dose but were
not statistically significant when compared directly to
matched control animals. In comparison to historical
control data, the incidences of hemangiomatous tumors
in the dosed mice were elevated, but not greatly. The
evidence was considered insufficient to conclusively
relate the hemangiomatous tumors in mice to compound
administration. Nonneoplastic proliferative and chronic
inflammatory lesions were also found in the spleens of
dosed rats and mice.
The findings of small numbers of fibromas and sar-
comas in the spleens of male rats was considered
strongly suggestive of carcinogenicity because of the
rarity of these tumors in the spleens of control rats.
Hemangiomatous tumors in dosed mice may also have
been associated with administration of p-chloroaniline.
However, itis concludedthat,undertheconditions ofthis
bioassay, sufficient evidence was not found to establish
the carcinogenicity of p-chloroaniline for Fischer 344
rats or B6C3F1 mice.
Synonyms: 4-chlorobenzeneamine; 4-chloropheny-
lamine; 4-chloroaniline; 4-CA; 1-amino-4-chlorobenzene
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Equivocal
Negative
Equivocal
Equivocal
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TR-190 Bioassay of
p-Nitrosodiphenylamine for Possible
Carcinogenicity (CASNo. 156-10-5)
p-Nitrosodiphenylamine is used to accelerate the vul-
canization ofrubber. Itis also used as anintermediate in
the manufacture ofdyes andpharmaceutical compounds
and as an inhibitor ofpolymerization duringthe produc-
tion ofvinyl monomers such as styrene.
Abioassay for the possible carcinogenicity ofp-nitro-
sodiphenylamine was conducted using Fischer 344 rats
and B6C3F1 mice. p-Nitrosodiphenylamine was admin-
istered in the feed, at either of two concentrations, to
groups of 50 male and female animals of each species.
Twenty animals of each sex and species were placed on
test as controls. The high andlowdietaryconcentrations
of p-nitrosodiphenylamine were, respectively, 5000 and
2500 ppm for rats. The high and low time-weighted
averageconcentrations formicewere9000and4254 ppm,
respectively. The compound was administered for 78
weeks to rats, for 50 weeks to high dose mice and for 57
weeks to low dose mice. The period ofcompound admin-
istration was followed by an observation period of 27
weeks for rats and 35 weeks for mice.
There were significant positive associations between
the concentrations of p-nitrosodiphenylamine admin-
istered and mortality among male and female mice, but
not for rats ofeither sex. Although 19/50 high dose male
mice and 21150 high dose female mice died before week
52, adequate numbers of mice and rats survived suffi-
ciently long to be at risk from late-developing tumors.
The toxicity observed in mice and the dose-related mean
bodyweightdepression apparentinmale andfemalerats
indicated that the concentrations of p-nitro-
sodiphenylamine administered to these animals in this
bioassay mayhaveapproached orexceededthemaximum
tolerated concentrations.
In male rats, there was a significant positive associa-
tion between concentration administered and the inci-
dence of a combination ofhepatocellular carcinomas and
neoplastic nodules. In addition, both the high dose to
control and the low dose to control Fischer exact com-
parisons were significant. There was also a significant
positive association between concentration administered
and the incidence of alveolar/bronchiolar adenomas in
male rats; however, neither of the Fischer exact com-
parisons weresignificant. There were nopositive, signifi-
cant statistical tests for tumor incidence at any site in
female rats.
Due to the large number of early deaths among high
dose mice of both sexes, the statistical conclusion con-
cerning carcinogenicity was based on comparisons
between the low dose and control groups. The incidence
of hepatocellular carcinomas was significantly higher
among the low dose males than among their controls.
Although hepatocellular neoplasms were observed in
dosed females, there were no tumors occurring with a
statistically increased incidence when low dose females
were compared to their controls.
Under the conditions of this bioassay, p-nitro-
sodiphenylaminewascarcinogenicwhenadministeredin
the diet to male B6C3F1 mice, causing hepatocellular
carcinomas. The chemical was also carcinogenic in male
Fischer 344 rats, causing liver neoplasms. No evidence
was provided for the carcinogenicity of p-nitro-
sodiphenylamine in female B6C3F1 mice or in female
Fischer 344 rats.
Synonyms: 4-nitroso-N-phenylbenzeneamine; 4-nitro-
sodiphenylamine; p-nitroso-N-phenylaniline; TKB
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Negative
Male Mice: Positive
Female Mice: Negative
TR-191 Bioassay ofTechnical Grade
Bis(2-chloro-1-methylethyl) ether for
Possible Carcinogenicity (CAS No.
108-60-1)
Bis(2-chloro-1-methylethyl) ether is a beta-haloether
and abyproduct ofpropylene oxide and propylene glycol
manufacture.
A bioassay of technical grade bis(2-chloro-1-
methylethyl) ether for possible carcinogenicitywas con-
ducted by administering the test chemical by gavage to
F344 rats.
Groups of 50 rats of each sex were administered a
solution ofbis(2-chloro-1-methylethyl) ether in corn oil 5
days per week at either 100 or 200 mg/kg/day for 103
weeks. Vehicle controls consisted ofgroups of50 rats of
each sex that were administered the corn oil alone.
Untreated-control groups of the same size were also
used. All surviving rats were killed at week 104 or 105.
Mean body weights of the dosed groups of male and
female rats were lower than those ofthe corresponding
vehicle-control groups throughout most ofthe study and
were dose related. Similarly, survivals of the high-dose
males and of both the high- and low-dose females were
lower than those of the corresponding vehicle controls
and were dose related. Almost all animals in the high-
dose groups died by the end ofthe bioassay.
No tumors occurred in the dosed groups of rats of
either sex at incidences that were significantly higher
than those ofthe vehicle-control groups.
It is concluded that under the conditions of this bio-
assay, the technical-grade test material, bis(2-chloro-1-
methylethyl) ether, was notcarcinogenic for F344 rats of
either sex.
Synonym: bis(2-chloro-isopropyl) ether
Report Date: 1979
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Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Negative
Negative
Note: Bis(2-chloro-1-methylethyl)ether was subse-
quently tested in B6C3F1 mice by gavage (See TR-239,
reported 1982).
TR-192 Bioassay ofMalathion for
Possible Carcinogenicity (CAS No.
121-75-5)
Malathion is an organophosphate insecticide consid-
ered to be suitable as a substitute for certain uses of
DDT. U.S. consumption in 1974 was 16 million pounds,
surpassingthatofallotherorganophosphateinsecticides
except methyl parathion. Household applications
accounted for approximately 10% ofthat volume.
A bioassay of malathion for possible carciniogenicity
wasconductedbyadministeringthetestchemicalinfeed
to F344 rats.
Groups of 49 or 50 rats of each sex were fed diets
containing 2,000 or 4,000 ppm malathion for 103 weeks
and were then observed for an additional 2 or 3 weeks.
Matched controls consisted of50 untreated rats ofeach
sex. All surviving rats were killed at 105 or 106 weeks.
No tumors occurred in the dosed groups of rats of
either sex at incidences that could be related clearly to
administration of the test chemical. Compound-related
toxiceffects werenotobservedinfemaleratsatthedoses
used, but in males decreased mean body weights,
increased mortality, gastritis, and gastric ulcers were
dose related.
It was concluded that under the conditions of this
bioassay, malathion was not carcinogenic in male or
female rats, but the females may not have received a
maximum tolerated dose.
Synonym: S-(1,2-bis(ethoxycarbonyl)-ethyl) 0, 0-
dimethylphosphorodithioate
Report Date: 1979
Levels of Evidence ofCarcinogenicity:
Male Rats:
Female Rats:
Negative
Negative
Note: Malathion was previously tested in Osborne-
Mendel rats and B6C3F1 mice administered infeed (See
TR-24, reported 1978).
TR-193 Bioassay ofResperine for
Possible Carcinogenicity (CAS No. 50-55-5)
A bioassay for possible carcinogenicity of resperine,
an antihypertensive drugfor human use, was conducted
by administering the test chemical in feed to F344 rats
and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered resperine attwo doses, 5 ppm and 10 ppm,
for 103 weeks and then observed for an additional 2
weeks. Matchedcontrolsconsistedofgroupsof50untre-
atedratsand50untreatedmiceofeachsex.Allsurviving
animals were killed and necropsied at the end of104 or
105weeks.
The significant effects that could be related to admin-
istration ofresperine at the doses used were decreased
body weight and increased tumor formation in dosed
malerats andinmice ofboth sexes. Dosedmaleratshad
an increased incidence of adrenal medullary phe-
ochromocytomas. Among dosed mice, some males devel-
opedundifferentiated carcinomasoftheseminalvesicles,
which rarely occur in control mice, and females had an
increased incidence ofmammary cancer.
It was concluded that, under the conditions of the
bioassay, resperinewas carcinogenic in male rats and in
mice of both sexes, producing three different kinds of
cancers. Resperinewas not carcinogenic forfemale rats,
but they may not have received a high enough dose for
maximum test sensitivity.
Report Date: November 1982
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
TR-194 Bioassay of Selenium Sulfide
(Gavage) for Possible Carcinogenicity
(CASNo. 7446-34-6)
Selenium sulfide is an ingredient in dandruff sham-
poos used in concentrations of1% in products sold over-
the-counter and 2.5% in products which are available by
prescription only. Prescription shampoos have been
shown in clinical studies to be of therapeutic value
against dandruff. An antimitotic mechanism ofaction is
suggested by data showing that selenium sulfide
decreases the rate of incorporation of radioactively
labeledthymidineintotheDNAofdermalepithelialcells.
Approximately200 kgofselenium sulfide is estimated to
be used annually for this purpose.
A bioassay of selenium sulfide for possible carcino-
genicitywas conducted by administering this substance
by gavage to F344 rats and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered selenium sulfide suspended in 0.5% aque-
ous carboxymethylcellulose 7 days per week for 103
weeks at either 3 or 5 mg/kg/day for rats and 20 or 100
mg/kg/dayformice.Asvehiclecontrols, groups of50rats
and 50 mice ofeach sexwere administered onlythe 0.5%
aqueous carboxymethylcellulose. Similar groups of
untreated controls alsowereused.Allsurvivingrats and
mice were killed and necropsied at week 104 or 105.
The significant effects that could be related to admin-
istration of selenium sulfide at the doses used were
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decreasedbodyweightandincreasedtumorformationin
female mice and in rats of each sex. Dosed rats and
femalemicehad anincreasedincidence ofhepatocellular
carcinomas and adenomas. Dosed female mice also had
an increased incidence of alveolar/bronchiolar car-
cinomas and adenomas.
Underthe conditions ofthisbioassay, selenium sulfide
wascarcinogenicforF344ratsandfemaleB6C3F1 mice,
including hepatocellular carcinomas in male and female
rats and female mice and alveolar/bronchiolar car-
cinomas and adenomas in female mice. Selenium sulfide
was not carcinogenic for male mice; but they have been
able to tolerate higher doses.
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Positive
Note: Selenium sulfide was subsequently tested in ICR
Swissmiceadministereddermally(SeeTR-197,reported
1980).
TR-195 Bioassay ofFluometuron for
Possible Carcinogenicity (CAS No.
2164-17-2)
Fluometuronisaphenylureaherbicideusedinagricul-
ture to control broad-leaved and grass weeds in cotton
and sugarcane fields. The area of heaviest use is the
Mississippi delta. Applications of low concentrations
selectively kill weeds.
Abioassayofthephenylureaherbicidefluometuronfor
possiblecarcinogenicitywasconductedbyadministering
the test chemical in feed to F344 rats and B6C3F1 mice.
Groups of50rats ofeach sexwere fed diets containing
125 or250ppm offluometuron for103weeks, and groups
of 50 mice of each sex were fed diets containing 500 or
1,000 ppm of fluometuron for 103 weeks. Matched con-
trols consisted of groups of 50 untreated rats and 25
untreated mice of each sex. All surviving animals were
killed at 103 to 105 weeks.
Splenomegalyobserved inratsinthe subchronic stud-
iesinfluencedselectionofthedosesforthechronicstudy;
however, no splenic effects were observed in the chronic
study.
Mean body weights of the dosed groups of male and
female rats and mice were essentially the same as those
of the corresponding control groups. Survival of dosed
groups of rats and mice was similar to that of the
corresponding control groups. Similarities between
mean body weights and survival between dosed and
control animals in the chronic study suggest that these
animals could have tolerated higher doses.
The onlypossible carcinogenic effects from compound
administration were in male mice. Incidences of
hepatocellular carcinomas or adenomas in male mice
were dose related, and the incidence in the high-dose
group was marginally higher than that in the corres-
ponding matched controls or pooled controls from con-
current studies.
Undertheconditionsofthisbioassay,fluometuronwas
not carcinogenic for F344 rats or for female B6C3Fj
mice. Equivocal results were obtained for male B6C3F1
mice which may have had an increased incidence of
hepatocellulartumors. Because ofthe equivocalfindings
and because both rats and mice may have been able to
tolerate higher doses, it is concluded that additional
testing offluometuron for carcinogenicity is warranted.
Synonym: 1,1-dimethyl-3-(a,a,a-trifluoro-m-tolyl) urea
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Equivocal
Negative
TR-196 Bioassay of Cinnamyl
Anthranilate for Possible Carcinogenicity
(CASNo.87-29-6)
A bioassay of cinnamyl anthranilate (a synthetic fla-
voringagent) forpossible carcinogenicitywasconducted
by administering the test chemical in feed to F344 rats
and B6C3F1 mice.
Groups of50 rats and 50 mice ofeach sexwere fed the
testchemicalindietscontaining15,000 or30,000ppmfor
103 weeks and then observed for an additional 2 or 3
weeks. Controls consisted ofgroups of50 untreated rats
and 50untreated mice ofeach sex. All survivinganimals
were killed and necropsied at 105 to 107 weeks.
Meanbodyweights ofthe dosed male and female rats
and mice were lower than those of the corresponding
controlsthroughoutthebioassay, andweightdecrements
weredoserelated.Mortalityinratsandmiceofeithersex
was not affected by administration ofthe test chemical.
In male rats, adenocarcinomas or adenomas of the
renal cortex and acinar-cell carcinomas or adenomas of
the pancreas were found in low incidences in dosed rats
but not in control rats. In direct comparisons with
matched control groups, the incidences of these tumors
were not significantlyincreased; however, because these
tumors rarely occur spontaneously in aging F344 rats,
theywere considered to be related to compound admin-
istration. Similar pancreatic or renal tumors have not
been detected among 634 historical-control male F344
rats at the same laboratory.
In the female rats, no tumors occurred at incidences
that could be clearly related to the administration ofthe
test chemical.
In both male and female mice, the incidences of
hepatocellular carcinomas or adenomas were dose
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related (P<0.001) and significant (P<. 0.001) in direct
comparisons ofdosed and control groups.
It was concluded that under the conditions of this
bioassay cinnamyl anthranilate was carcinogenic for
male and female B6C3F1 mice, inducing increased inci-
dences of hepatocellular carcinomas or adenomas. The
test chemical was also carcinogenic for male F344 rats,
inducinglowincidences ofacinar-cell carcinomas orade-
nomas of the pancreas and adenocarcinomas or ade-
nomas of the renal cortex. Cinnamyl anthranilate was
not carcinogenic for female F344 rats.
Synonyms: 2-aminobenzoic acid, 3-phenyl-2-propenyl
ester; anthranilic acid, cinnamyl ester
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
TR-197 Bioassay of Selenium Sulfide
(Dermal Study) for Possible
Carcinogenicity (CAS No. 7446-34-6)
Seleniumisanessentialnutrient, andvariousselenium
compounds have industrial and medical uses.
The possible carcinogenicity of selenium sulfide (a
component in shampoos) was investigated by applying a
suspension of this substance to the skin of ICR Swiss
mice. Groups of 50 mice of each sex were treated by
applying 0.5 mg or 1.0 mg selenium sulfide three times a
week for 86 weeks to a clipped 2- x 3-cm dorsal surface.
The selenium sulfide was suspended in 0.05 ml saline
solution containing 0.5% carboxymethylcellulose.
Mean body weights of all dosed and control groups
werecomparablethroughoutthestudy.Amyloidosis,pre-
viouslyreported as a cause ofdeath in Swissmice, was a
factor in the deaths of most treated and control mice
after1year,andthestudywasterminatedafter88weeks
when the majority of animals in all dosed and control
groups had died.
Under the conditions ofthis bioassay, dermal applica-
tion of selenium sulfide did not produce a carcinogenic
effectinICRSwissmice, butthestudywaslimitedbythe
relatively short lifespan ofthis strain ofmouse.
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Mice: Negative
Female Mice: Negative
Note: Selenium Sulfide was previously tested in F344
and B6C3F1 mice administered by gavage (See TR-194,
reported 1980).
TR-198 Bioassay ofa Mixture of
L2,3,6,7,8-Hexachlorodibenzo-p-dioxin and
1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin
(Gavage) for Possible Carcinogenicity
(CAS No. 57653-85-7, CAS No. 19408-74-3)
Hexachlorodibenzo-p-dioxins (HCDD) are formed dur-
ing the manufacture of certain chlorophenols. They have
been found in trichlorophenol, tetrachlorophenol, and pen-
tachlorophenol and in the chlorophenol-derived herbicides,
2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-
trichlorophenoxyacetic acid (2,4,5-T). From 1967 to 1970,
the concentration of HCDD in commercial pentachloro-
phenol ranged from 0.03 to 38 ppm. Since then, HCDD
levels in pentachlorophenol have been less than 1 ppm.
A bioassay of a mixture of 1,2,3,6,7,8- and 1,2,3,7,8,9-
hexachlorodibenzo-p-dioxin (HCDD) for possible car-
cinogenicity was conducted by administering the test
materialbygavage to Osborne-Mendel rats andB6C3Fj
mice for 104 weeks.
Fifty rats and 50 mice ofeach sex were administered
HCDD suspended in a vehicle of 9:1 corn oil-acetate 2
daysperweekfor104weeks atdoses of1.25,2.5, or5 jig/
kg/wk for rats and male mice and 2.5, 5, or 10 ,ug/kg/wk
forfemalemice. Seventy-fiveratsand 75miceofeach sex
served as vehicle controls. In addition, one untreated
control group containing 25 rats and 25 mice ofeach sex
was present in the HCDD treatment room, and one
untreatedcontrolgroupcontaining25ratsand25miceof
each sex was present in the vehicle control room. All
surviving animals were killed at 105 to 108 weeks.
Inrats, adose-relateddepressioninmeanbodyweight
gain became evident in the males after week 68 of the
bioassay and in the females after week 33. In mice, the
meanbodyweight gain inthe dosed groupswas compar-
ablewiththatofthevehiclecontrolgroups.Noothertoxic
clinicalsignswerereportedineithertherats orthemice.
Administration of HCDD had no adverse effect on the
survival ofeither species.
In male rats, hepatocellular carcinomas or neoplastic
nodulesoccurredatlowincidencesthatweredoserelated
(P=0.003). Inadirectcomparison, theincidence ofthese
tumors in the high-dose group was higher (P= 0.022)
than that in the corresponding vehicle-control groups,
buttheBonferronirequirementofP=0.017forthemulti-
ple comparison of three dosed groups with a control
group was not met.
In female rats, hepatocellular carcinomas, adenomas,
or neoplastic nodules occurred at incidences that were
dose related (P<0.001), and in direct comparisons the
incidences of these tumors in the mid- and high-dosed
groupsweresignificantlyhigher(P=0.006 andP<0.001,
respectively) than those in the corresponding vehicle-
control group.
In male mice, hepatocellular carcinomas or adenomas
occurred at incidences that were dose related (P=0.001),
andin adirectcomparisontheincidenceofthese tumorsin
the high-dose group was significantly higher (P=0.001)
than that in the correspondingvehicle-control group.
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In female mice, hepatocellular carcinomas or ade-
nomas occurred at incidences that were dose-related
(P=0.002), andtheincidence ofthesetumorsinthehigh-
dose groupwas significantly higher (P=0.004) thanthat
in the corresponding vehicle-control group.
Complex nonneoplastic toxic liver lesions were seen in
all dosed groups ofrats and mice. Compound-associated
hyperplastic lesions ofthe lung were also found in both
male and female rats.
Under the conditions ofthis bioassay, HCDD admin-
istered by gavage was carcinogenic, causing increased
incidences of hepatocellular carcinomas or neoplastic
nodules in female Osborne-Mendel rats and inducing
hepatocellular carcinomas and adenomas in male and
female B6C3F1 mice. HCDDwas notdemonstrated tobe
carcinogenic for male rats.
Synonym: HCDD
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats: Equivocal
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
Note: 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin and
1,2,3,7,8.9-Hexachlorodibenzo-p-dioxin were subse-
quently tested in Swiss-Webster mice administered der-
mally (See TR-202, reported 1980).
TR-199 Bioassay ofSelsun® for Possible
Carcinogenicity
AbioassayofSelsun® forpossible carcinogenicitywas
conducted by applying this substance dermally to ICR
Swiss mice. Selsun®, an antidandruffshampoo, contains
2.5% selenium sulfide.
Groups of50 mice ofeach sexwere exposed to 0.05 ml
of 25% or 50% Selsun® in distilled water three times a
week on a 2- x 3-cm clipped dorsal surface. Vehicle
controls consisted of 50 mice of each sex that were
clipped and treated with distilled water. Untreated con-
trols consisted of 50 mice of each sex that were only
clipped. Surviving mice were killed and necropsied at
week 88.
Mean body weights ofuntreated control, vehicle con-
trol, low-dose, and high-dose groups were comparable
throughout the bioassay. Amyloidosis was afactor in the
deaths of most animals after 1 year. In male mice,
alveolar/bronchiolar carcinomas or adenomas occurred
with adose-related trend thatwassignificant (P =0.008).
The result of the Fisher exact test comparing the inci-
dence in the high-dose group with that in the vehicle
controls is also significant, but the incidence ofthe high-
dose group, when compared with that of the untreated
controls, is not significant.
Under the conditions ofthis bioassay, dermal applica-
tion ofSelsun® was notcarcinogenic for ICR Swiss mice.
The study was limited, however, by the relatively short
lifespan ofthis strain ofmouse.
Report Date: August 1980
Levels of Evidence of Carcinogenicity:
Male Mice:
Female Mice:
Negative
Negative
TR-200 Bioassay of 2,6-Toluenediamine
Dihydrochloride for Possible
Carcinogenicity (CAS No. 15481-70-6)
2,6-Toluenediamine is used as an intermediate in the
production of dyes for furs and textiles, and of flexible
polyurethane foams and elastomers. A bioassay of 2,6-
toluenediamine dihydrochloride for possible car-
cinogenicity was conducted by feeding diets containing
the test chemical to F344 rats and B6C3F1 mice.
Groupsof50ratsofeachsexwerefedthetestchemical
attwo doses, 250 or500ppm, for103weeks and observed
for 1 additionalweek. Groups of50 mice ofeach sexwere
fed the test chemical at two doses, 50 or 100 ppm, for 103
weeks andthenobservedfor1additionalweek. Groups of
50untreated rats and 50untreated mice ofeach sexwere
used as matched controls. All surviving animals were
killed and necropsied at 104weeks.
Weight gain depression was less than 10% for dosed
groups of male rats and male and female mice, when
compared with controls. Mean body weight gain was
depressed 17% in low-dose female rats and 27% in high-
dose female rats. Mortality was not increased in rats or
mice of either sex by the test chemical. No clinical
evidence indicated that mice of either sex received a
maximum tolerated dose ofthe compound.
In male rats, islet-cell adenomas of the pancreas and
neoplastic nodules or carcinomas ofthe liver occurred in
dose-related trends that were significant using the
Cochran-Armitage test (P=0.025 and P=0.037, respec-
tively). The results of the Fisher exact test were not
significantforeitherlesion.Theoccurrences oftumorsin
dosed female rats were not significantly different from
those in control rats.
Significant results in the negative direction were
observed intheincidences ofC-celltumors ofthethyroid
inmalerats and offibroadenomas ofthemammarygland
in female rats.
In male mice, in the low-dose group, lymphomas
occurred at an incidence significantly higher (P=0.046)
than that of the corresponding control group; however,
the incidence was not significant when the Bonferroni
criterion for multiple comparison was used.
The occurrence ofhepatocellularcarcinomas infemale
mice was dose related, but the result ofthe Fisher exact
testcomparingtheincidence inthehigh-dose groupwith
that in the controls was not significant.
It was concluded that, under the conditions of the
bioassay, 2,6-toluenediamine dihydrochloride was not
illlNTP/NIEHS
carcinogenic for male and female F344 rats or for male
and female B6C3F1 mice.
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-201 Carcinogenesis Bioassay of
2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS
No. 1746-01-6) in Swiss-Webster Mice
(DermalStudy)
2,3,7,8-Tetrachlorodibenzo-p-dioxin occurs as ahighly
toxic impurity found in herbicides containing 2,4,5-
trichlorophenoxyacetic acid (2,4,5-T) and 2,4,5-T deriva-
tives, as well as in other chemicals synthesized using
2,4,5-trichlorophenol.
Theherbicide2,4,5-Thasbeenmarketed inthe United
States since 1948. Production increased sharplybetween
1960 and 1970 when a 1:1 mixture of 2,4,5-T and 2,4-
dichlorophenoxyacetic acid (2,4-D) was used as a
defoliantinVietnamunderthe names of"herbicide agent
orange, herbicide orange, agent orange, and orange".
During this 10-year period, about 106 million pounds of
2,4,5-T were sprayed.
A carcinogenesis bioassay was conducted by applying
an acetone suspension of 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) to the clipped backs of 30 male and
female Swiss-Webster mice 3 days perweek for 99 or104
weeks. Similar groups werepretreated with 1 application
of 50 pug dimethylbenzanthracene (DMBA) in 0.1 ml
acetone 1 week before TCDD administration began.
Female mice received 0.005 ,ug TCDD per application,
and the male mice received 0.001 ,ug TCDD. As vehicle
controls, 45miceofeach sexreceived 0.1mlacetonethree
times perweek. Thirty animals ofeach sex were used as
untreated controls.
Throughout the bioassay, mean body weights of the
male and female mice administered TCDD, or TCDD
following DMBA, were essentially the same as those of
the corresponding vehicle control group. Mean body
weights of dosed and vehicle control groups of males
were less than those of the untreated control group
throughout the study; for the females, mean body
weights were less than theuntreated controls duringthe
first 80 weeks.
In female mice, the incidences of fibrosarcoma in the
integumentary systemin dosed groupswithTCDD were
significantly (P =0.007) higher than that in the corres-
ponding controls (2/41, 5%; 8/27,30%). An increase inthe
same tumor type, although not statistically significant
(P =0.084), was also observed inthemalemice (3/42, 7%;
6/28, 21%).
In the DMBA-TCDD experiment, failure to have
included groups skinpaintedwith onlyDMBAprecluded
interpretation ofthese results.
Under the conditions of this bioassay, 2,3,7,8-
tetrachlorodibenzo-p-dioxin applied to the skin was not
carcinogenic for male Swiss-Webster mice (the increase
offibrosarcomas in the integumentary systemmayhave
been associated with the skin application of TCDD).
TCDD was carcinogenic for female Swiss-Webster mice
causing fibrosarcomas in the integumentary system.
Synonyms: 2,3,7,8-TCDD; TCDD
Report Date: February 1982
Note: 2,3,7,8-Tetrachlorodibenzo-p-dioxin was subse-
quentlytestedinOsborne-Mendelrats andB6C3F1 mice
by gavage (See TR-209 reported 1982).
TR-202 Bioassay of a Mixture of
1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin and
1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin
(Dermal Study) for Possible
Carcinogenicity (CAS No. 57653-85-7; CAS
No.19408-74-3)
Hexachlorodibenzo-p-dioxin (HCDD) is formed as a
byproduct during the manufacture of certain chlo-
rophenolsandhasbeenfoundintrichlorophenol, tetrach-
lorophenol, pentachlorophenol and in the chlorophenol-
derivedherbicides2,4-dichlorophenoxyacetic acid(2,4-D)
and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T). From
1967 to 1970, the concentration ofHCDD in commercial
pentachlorophenol ranged from 0.03 to 38 ppm. Since
then, HCDD levels in pentachlorophenol have been
reduced to less than 1 ppm.
A bioassay of a mixture of 1,2,3,6,7,8- and 1,2,3,7,8,9-
hexachlorodibenzo-p-dioxins (HCDD) for possible car-
cinogenicity was conducted by dermal application of a
suspension ofthis substance to Swiss-Webster mice.
HCDD (0.01 ,ug) suspended in 0.1 ml acetone was
applied to the backs of 30 mice of each sex 3 days per
weekfor104weeks.Duringthefirst16weeks,doseswere
0.005 ,ugHCDD perapplication.An additional30mice of
each sex were pretreated with one application of 50 p,g
DMBAin0.1ml acetone1weekbeforetheinitiationofthe
HCDD applications. As vehicle controls, 45 mice ofeach
sex received 0.1 ml of acetone three times per week.
Thirty animals ofeach sex served as untreated controls.
Mean body weights of all test and vehicle control mice
were comparable throughout the bioassay; mean body
weights ofuntreated controls were higher than those of
the test and vehicle-control groups.
In male mice, the incidence of alveolar/bronchiolar
carcinomas in the group administered only HCDD was
significantly higher (P=0.045) than that in the vehicle-
control group; however, the incidence was not signifi-
cantly higher when compared with untreated controls.
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In female mice, the incidences offibrosarcomas ofthe
skin were significantly higher (P=0.044) in animals
administered HCDD (both with and without pretreat-
ment with DBMA) than in the untreated-control group;
however, when the incidences were compared with those
of the vehicle controls (relative risk=3.037) the results
were not significant.
Under the conditions ofthis bioassay, HCDD was not
carcinogenic for male or female Swiss-Webster mice.
Synonym: HCDD
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Mice:
Female Mice:
Negative
Negative
Note: Hexachlorodibenzo-p-dioxin and 1,2,3,7,8,9-
hexachlorodibenzo-p-dioxin were previously tested in
Swiss-Webstermiceadministered dermally(SeeTR-198,
reported 1980).
TR-203 Bioassay ofPhenol for Possible
Carcinogenicity (CAS No. 108-95-2)
Phenol ranked 38th in production among U.S. chemi-
calsin 1978with annualproductionof2.38billionpounds.
Approximately 90% ofthephenolproduced is usedinthe
manufacture of phenolic (phenol formaldehyde) resins,
caprolactam, bisphenol A, alkyl phenol, and adipic acid.
The remainder of the phenol is used to produce an
assortment ofendproducts, includingsalicylic acid, phe-
nacetin, dyes, metal cleaners, disinfectants, antiseptics,
photographic chemicals, wood preservatives (pen-
tachlorophenol), paints, paint and varnish removers, and
agricultural chemicals (2,4-D and parathion).
A bioassay of phenol to test for possible car-
cinogenicity was conducted by providing this substance
indrinkingwater to F344rats andB6C3F1mice. Groups
of 50 rats and 50 mice of each sex were given drinking
watercontaining2,500or5,000ppmphenolfor103weeks.
As matched controls, groups of 50 rats and 50 mice of
each sex received tap water.
A dose-related depression in mean body weight gain
occurred in rats and mice of each sex. Rats and mice
given water containing phenol drank less than did the
correspondingcontrols.Adose-related decreaseinwater
consumption was observed for mice.
An increased incidence ofleukemia orlymphomas was
detected inmale rats andmayhavebeen associated with
the administration ofphenol. Although the incidence of
these tumors in the low-dose group was significantly
higher than that in controls, the incidence in the high-
dose group was not. Thus an association with admin-
istration ofphenol was not established.
Under the conditions ofthis bioassay, phenol was not
carcinogenic for either male orfemale F344 rats or male
and female B6C3F1 mice.
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-204 Bioassay ofBenzoin for Possible
Carcinogenicity(CASNo.119-53-9)
Abioassayofbenzoin forpossible carcinogenicitywas
conducted by incorporating the test chemical in diets of
F344 rats and B6C3F1 mice. Benzoin is used as a pho-
topolymerization catalyst, chemical intermediate, and
flavor ingredient.
Groupsof50maleratswerefeddietscontaining125 or
250 ppmbenzoin for104weeks, and similar groups offe-
male rats received feed containing 250 or 500 ppm.
Groups of50 mice ofeach sex were fed diets containing
2,500 or 5,000 ppm, benzoin for 104 weeks. Groups of50
untreated rats and mice of each sex were used as
matched controls. Rats and mice of either sex probably
couldhavetoleratedhigherdoses.Anincreasedincidence
oflymphomas or leukemia occurred in dosed male rats,
butthe observed dose-related trend was not statistically
significant.
Mean body weights and clinical signs of low-dose,
high-dose, and control male and female rats and male
mice were comparable throughout the study, Afterweek
44,meanbodyweightsofdosedfemalemicewereslightly
lower (10% or less) than those ofthe controls.
The incidences of lymphomas that occurred in male
mice varied with each dose but were not statistically
significant when compared with those of matched con-
trols.
Lymphomas orleukemias occurred in low-dose female
mice at anincidence thatwas significantwhen compared
with the matched controls. However, because the inci-
denceoflymphomasorleukemiasinthehigh-dosefemale
micewas notsignificant, the occurrence ofthese tumors
was not clearly related to administration of the test
compounds.
Underthe conditions ofthisbioassay, benzoin was not
carcinogenic for F344 rats or B6C3F1 mice.
Synonym: 2-hydroxy-1,2-diphenylethanone
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
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TR-205 Bioassay of4,4'-Oxydianiline for
Possible Carcinogenicity (CAS No.
101-80-4)
4,4'-Oxydianiline is used in the manufacture of high
temperature resistant metal adhesives, molding and
machine parts, and insulators. Abioassay ofthis chemi-
calforpossiblecarcinogenicitywas conductedbyfeeding
diets containing200, 400, or500ppmofthetestchemical
to groups of50male orfemale F344 rats and 150, 300, or
800 ppm to groups of50male orfemale B6C3F1 micefor
104 weeks. Matched controls consisted of 50 untreated
rats and 50 untreated mice of each sex. All surviving
animals were killed at 104 to 105 weeks.
A dose-related decrement in mean body weight gain
was observed for all groups of dosed rats and mice.
Survival was significantly shortened in the high-dose
female rats and in the low- and mid-dose female mice.
In male and female rats, hepatocellular carcinomas or
neoplasticnodulesoccurredatincidencesthatweredose-
related, and the incidences in all dosed groups (except
low-dosefemales) were higherthanthose inthe controls.
The occurrence offollicular-cell adenomas orcarcinomas
ofthe thyroid was dose-related. Among groups of male
andfemalerats, theincidences inthe mid- andhigh-dose
groups ofeither sexwere significantly higherthan those
ofthe corresponding controls.
In male and female mice, adenomas in the harderian
glands occurred in all dosed groups at incidences that
were significantly higher than the incidence in the
matched controls.
In low-dose male mice and in high-dose female mice,
hepatocellular adenomas orcarcinomas occurred atinci-
dences significantly higher than those in the matched
controls.
In female mice, follicular-cell adenomas in the thyroid
occurred with a positive linear trend, and in a direct
comparisontheincidenceinthehigh-dosegroupwasalso
significantly higher than that in the controls.
Thmors occurring among male mice at increased inci-
dences which could not be statistically related to the
chemical were adenomas in the pituitary and
hemangiomas ofthe circulatory system.
Underthe conditions ofthisbioassay,4,4'-oxydianiline
wascarcinogenicformaleandfemale F344rats,inducing
hepatocellularcarcinomas orneoplastic nodules andfolli-
cular-cell adenomas or carcinomas of the thyroid. 4,4'-
Oxydianiline was also carcinogenic for male and female
B6C3F1 mice, including adenomas in the harderian
glands, hepatocellular adenomas or carcinomas in both
sexes, and follicular-cell adenomas in the thyroid of
females.
Report Date: August 1980
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-206 Carcinogenesis Bioassay of1,2-
Dibromo-3-chloropropane (CAS No. 96-12-8)
in F344 Rats and B6C3F1 Mice (Inhalation
Study)
1,2-Dibromo-3-chloropropane (DBCP), a contaminant
(0.05%) of the flame retardant tris(2,3-dibromopropyl)-
phosphate, hasbeenusedprimarily as a soil fumigantto
control nematodes. Unlike other halogenated
nematocides, DBCP can be applied to soil without
damaginggrowingperennials. Sinceitis slightly soluble
in water at the concentrations used (30 ppm), DBCP can
be either injected directly into the soil or added to
irrigation water. By 1972, an estimated 12.3 million
pounds were being used annually; in 1977, a total of
832,000poundswereusedinCalifornia,mostlyongrapes
and tomatoes.
A carcinogenesis bioassay of technical grade 1,2-
dibromo-3-chloropropane (DBCP),whichcontainedtrace
amounts ofepichlorohydrin and 1,2-dibromoethane, was
conducted by exposing groups of 50 F344 rats and
B6C3F1 mice ofeach sexby inhalation to concentrations
of 0.6 or 3.0 ppm DBCP for 6 hours per day, 5 days per
week, for 76 to 103 weeks. Untreated chamber controls
consisted of 50 rats and 50 mice of each sex. Surviving
high-dose rats were killed at week 84. Surviving high-
dose female mice and low- and high-dose male micewere
killed at week 76. Low-dose rats and female mice were
killed at week 104.
Accelerated mortality occurred in the high-dose
groups of both species. Early deaths of high-dose rats
and mice were associated with respiratory tract tumors.
Interference with breathing and metastasis to the brain
were major contributing factors in these deaths. Among
male mice, accelerated mortality occurred in low-dose
and control groups as well as in the high-dose group.
Urogenital infection appeared to be associated with
these deaths.
Carcinomas, squamous-cell carcinomas, andadenocar-
cinomasofthenasalcavityandsquamous-cellpapillomas
of the tongue each occurred in high-dose male rats at
incidences significantly higher than those in the corres-
ponding controls. Adenocarcinomas, adenomas, ade-
nomatous polyps, and squamous-cell papillomas of the
nasal cavity and adenomatous polyps ofthe nasal turbi-
nates occurred in low-dose male rats with significantly
increased incidences relative to controls.
Carcinomas and adenocarcinomas ofthe nasal cavity,
squamous-cell papillomas of the tongue, squamous-cell
papillomas and carcinomas (combined) of the pharynx,
and adenomas of the adrenal cortex each occurred in
high-dose female rats at incidences significantly higher
thanthoseinthecorrespondingcontrols.Also, adenomas
and squamous-cell papillomas of the nasal cavity, ade-
nomas of the adrenal cortex, and fibroadenomas of the
mammaryglandwereincreased significantlyinlow-dose
female rats when compared with controls.
Adenocarcinomas of the nasal cavity in high-dose
female mice, papillary carcinomas in low-dose female
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mice, and carcinomas, squamous cell carcinomas of the
nasal cavity, and alveolar/bronchiolar adenomas or car-
cinomas of the lung in high-dose male and female mice
occurred at incidences significantly higher than those in
the corresponding controls.
Exposure to DBCP vapor was also associated with
toxic tubular nephropathy in rats and mice ofeither sex
andwith proliferative changes in the nasal mucosa, lung,
and forestomach in mice.
Under the conditions of this bioassay, DBCP was
carcinogenic for male and female F344/N rats, including
increased incidences ofnasal cavity tumors and tumors
ofthe tongue in both sexes, and cortical adenomas in the
adrenal glands of females. DBCP was carcinogenic in
male and female B6C3F1 mice, including increased inci-
dences ofnasal cavity tumors and lung tumors.
Synonyms: DBCP; dibromochloropropane; Nemagon;
Fumazone
Report Date: March 1982
Note: 1,2-Dibromo-3-chloropropane was previously
tested in Osborne-Mendel rats and B6C3F1 mice by
gavage (See TR-28, reported 1978).
TR-207 Carcinogenesis Bioassay of
Cytembena (CASNo. 21739-91-3)
A carcinogenesis bioassay of cytembena, a cytostatic
agent, was conducted by injecting intraperitoneally 7 or
14 mg/kginto groups of50 male and 50female F344 rats
and 12 or 24 mg/kg into groups of 50 male or 50 female
B6C3F1 micethreetimesperweekfor104weeks. Groups
of 50 rats and 50 mice of both sexes served as vehicle
controls.
Mean body weights of dosed and vehicle-control rats
were comparable throughout the bioassay. Mean body
weights ofdosed and vehicle-control mice were compar-
able for the first 73 weeks of the bioassay; mean body
weightofthehighdosemalemicewasslightlylowerthan
thatofthevehicle controls after 73weeks, andthatofthe
high-dose female mice was lower after week 87.
In dosed male rats, mesotheliomas in the tunica vagi-
nalis and malignant mesotheliomas in multiple organs
occurred with dose-related trends and at incidences in
each ofthe dosed groupswhichwere significantlyhigher
than those in the vehicle control rats.
In dosed female rats, fibroadenomas in the mammary
gland occurredwith adose-related trend and ata signifi-
cantly higher incidence in the high-dose group than in
vehicle control rats.
Under the conditions ofthis bioassay, cytembena was
carcinogenic for male and female F344 rats, causing
increasedinciolences ofmesotheliomas inthetunicavagi-
nalis and in multiple organs ofmales and fibroadenomas
in the mammary gland of females. Cytembena was not
carcinogenic for male or female B6C3F1 mice.
Synonyms: cytembene; 2-butenoic acid; 3-bromo-4-(4-
methoxyphenyl)-4-oxo-, sodium salt
Report Date: May 1981
TR-208 Carcinogenesis Bioassay of FD &
C Yellow No. 6 (CAS No. 2783-94-0)
A carcinogenesis bioassay was conducted using
groups of50 male and 50 female F344 rats and B6C3F1
mice which were fed diets containing 12,500 or 25,000
ppmFD & CYellowNo.6,awidelyusedfoodcolorant,for
103 weeks. Groups of90 male and 90 female rats and 50
male and 50 female mice served as undosed controls.
Throughout the study, mean body weights of high-
dose female rats and all low-dose groups were compar-
ablewith those ofthe controls, butmeanbodyweights of
high-dose male rats and high-dose male and female mice
were slightly lower (10% or less) than those of the
controls.
No compound-related neoplastic or nonneoplastic
lesions were observed in the rats.
The incidence of hepatocellular carcinomas in low-dose
malemicewassignificantlyhigherthanthatinthecontrols,
butthelackofasignificantincreaseinhigh-dosemalesand
the variability of liver tumors in B6C3F1 male mice pre-
cluded clearly relating the occurrence of these tumors to
the administration ofFD & C Yellow No. 6.
Under the conditions of this bioassay, there was no
clear evidence of the carcinogenicity of FD & C Yellow
No. 6 in F344 rats or B6C3F1 mice ofeither sex.
Synonym: Sunset Yellow FCF
Report Date: May 1981
TR-209 Carcinogenesis Bioassay of
2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS
No. 1746-01-6) in Osborne-Mendel Rats and
B6C3F1 Mice (Gavage Study)
A carcinogenesis bioassay of 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD), a contaminant in several phe-
noxyherbicides, was conducted by administering TCDD
by gavage to Osborne-Mendel rats and B6C3F1 mice for
104weeks.
Fifty rats and mice of each sex were given TCDD
suspended in a vehicle of 9:1 corn oil-acetone 2 days per
weekfor104weeks at doses of0.01, 0.05, or 0.5 pLg/kg/wk
for rats and male mice and 0.04, 0.2, or 2.0 pLg/kg/wk for
female mice. Seventy-five rats and 75 mice of each sex
served as vehicle controls. One untreated control group
containing25 rats and 25mice ofeach sexwas presentin
the TCDD treatment room, and one untreated control
group containing 25 rats and 25 mice of each sex was
present in the vehicle-control room. All surviving ani-
mals were killed at 105 to 108 weeks.
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Inrats, adose-related depressioninmeanbodyweight
gain was observed in the males after week 55 of the
bioassay and in the females after week 45. In mice, the
mean bodyweight gain inthe dosed groupswas compar-
able to that ofthe vehicle-control groups.
In male rats, increased incidences of follicular-cell
adenomas in the thyroid were dose related and were
significantly (P=0.001) higher in the high-dose group
thaninthevehiclecontrols(1/69,1%;5/48,10%;6/50,12%;
10/50, 20%). Similarly in the female rats, an increase
(thoughnotstatisticallysignificant)wasseeninthehigh-
dose group (3/73, 4%; 2/45, 4%; 1/49, 2%; 6/47,13%).
In female rats, the incidence of neoplastic nodules of
the liver in the high-dose group was significantly
(P=0.006) higher than that in the vehicle control group
(5/75, 7%; 1/49, 2%; 3/50, 6%; 12/49, 24%).
In male and female mice, incidences ofhepatocellular
carcinomas were dose related and the incidences in the
high-dose groupswere significantly (P=0.002 and 0.014,
respectively) higher than those in the corresponding
vehicle control groups (males: 8/73, 11%; 9/49,18%; 9/49,
16%; 17/50, 34%; females: 1/73, 1%; 2/50, 4%; 2/48, 4%;
6/47, 13%).
In female mice, follicular-cell adenomas in the thyroid
occurred at dose-related incidences, and were signifi-
cantly (P=0.009) higher in the high-dose groups than
those inthevehicle controls (0/69, 0%; 3/50,6%; 1/47,2%;
5/46, 11%).
Increased incidences of toxic hepatitis related to the
administration ofthetestchemicalwere detected among
high-dose rats and high-dose mice ofeach sex.
Under the conditions of this bioassay, 2,3,7,8-
tetrachlorodibenzo-p-dioxin was carcinogenic for
Osborne-Mendel rats, including follicular-cell thyroid
adenomas in males and neoplastic nodules ofthe liver in
females. TCDD was also carcinogenic for B6C3F1 mice,
including hepatocellular carcinomas inmale and females
and follicular-cell thyroid adenomas in females.
Synonyms: 2,3,7,8-TCDD; TCDD
Report Date: February 1982
Note: 2,3,7,8-Tetrachlorodibenzo-p-dioxin was pre-
viously tested in Swiss-Webster mice administered der-
mally (See TR-201, reported 1982).
TR-210 Carcinogenesis Bioassay of1,2-
Dibromoethane (CAS No. 106-93-4) in F344
Rats and B6C3F1 Mice (Inhalation Study)
A carcinogenesis bioassay of 1,2-dibromoethane, a
widely used nematocide and leaded gasoline additive,
was conducted by exposing groups of 50 F344 rats and
B6C3F1 mice ofeach sexbyinhalation to concentrations
of 10 or 40 ppm of the 1,2-dibromoethane for 78-103
weeks. Untreated controls consisted of 50 rats and 50
mice ofeach sex exposed in chambers to ambient air.
Throughout the study, mean body weights of high-
dose rats and high-dose mice of either sex were lower
than those ofthe correspondinguntreated controls. Sur-
vival of the high-dose rats of either sex and of the low-
andhigh-dosefemalemicewassignificantlyshorterthan
that in the corresponding controls.
Theprincipal cause ofearlydeathin control and dosed
male mice was ascending, suppurative urinary tract
infection that resulted in necrotic, ulcerative lesions
around the urethral opening, chronic or suppurative
cystitis (often with urinary tract obstruction), and
ascending suppurative pyelonephritis.
Carcinomas and adenocarcinomas ofthe nasal cavity
were observed with significantly increased incidences
(P<0.001) in high-dose rats of either sex relative to
controls. The incidences of adenocarcinomas and ade-
nomas of the nasal cavity were also significantly
increased (P<0.001) in low-dose rats ofeither sex. Ade-
nomatous polyps ofthe nasal cavityshowed significantly
increased incidence (P<0.001) inlow-dose malerats. The
combined incidence of alveolar/bronchiolar adenomas
and carcinomas was statistically significant (P=0.024)
for high-dose female rats.
Hemangiosarcomas ofthe circulatory system (mainly
spleen) and mesotheliomas of the tunica vaginalis
occurred in high-dose male rats with significantly
increased incidences (P<0.001) relative to controls.
Theincidenceoffibroadenomasofthemammarygland
was significantlyelevated (P<0.001)in dosedfemale rats
relative to controls.
The incidences of alveolar/bronchiolar carcinoma and
alveolar/bronchiolar adenoma were significantly
increased (P<0.001) in high-dose male mice relative to
controls. These tumors were also increased in high-dose
female mice (P=0.007 for adenomas and P<0.001 for
carcinomas).
Hemangiosarcomas occurred in low- and high dose
femalemice atincidences significantlygreater(P<0.001)
than the incidence in the controls (0/50). High-dose
femalemicealsohadsignificantlyincreasedincidencesof
subcutaneous fibrosarcomas (P<0.001) and ofnasal cav-
ity carcinomas (P= 0.013). Low-dose female mice also
showed a significantly increased incidence (P<0.001) of
mammary gland adenocarcinomas.
Exposure to 1,2-dibromoethane was also associated
with hepatic necrosis and toxic nephropathy in rats of
either sex, testicular degeneration in male rats, retinal
degeneration infemale rats, and epithelialhyperplasiaof
the respiratory system in mice.
Under the conditions of this bioassay, 1,2-
dibromoethane was carcinogenic for F344 rats, causing
increased incidences of carcinomas, adenocarcinomas,
adenomas ofthe nasal cavity, and hemangiosarcomas of
the circulatory system in males and females; meso-
theliomasofthetunicavaginalisandadenomatouspolyps
of the nasal cavity in males; and fibroadenomas of the
mammary gland and alveolar/bronchiolar adenomas and
carcinomas (combined) in females. 1,2-Dibromoethane
was carcinogenic for B6C3F1 mice, causing alveolar/
bronchiolar carcinomas and alveolar/bronchiolar ade-
nomas in males and females; and hemangiosarcomas of
the circulatory system, fibrosarcomas in the sub-
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cutaneous tissue, carcinomas of the nasal cavity, and
adenocarcinomas ofthe mammary gland in females.
Synonyms: ethylene dibromide; EDB; ethylene bromide
Report Date: March 1982
Note: 1,2-Dibromoethane was previously tested in
Osborne-Mendel rats and B6C3F1 mice by gavage (See
TR-86, reported 1978).
TR-211 Carcinogenesis Studies of C.I.
Acid Orange 10 (CAS No. 1936-15-8) in F344
Rats andB6C3F1 Mice (Feed Studies)
Carcinogenesis studies of80% pure C.I. Acid Orange
10 (a monoazo textile dye) were conducted by feeding to
groups of 50 male and 50 female F344/N rats diets
containing1,000 or3,000ppmC.I.Acid Orange10for103
weeks. Groups of 50 male and 50 female B6C3F1 mice
were fed diets containing 3,000 or 6,000 ppm for 103
weeks. Groups of 90 male and 90 female untreated rats
and 50 male and 50 female untreated mice served as
controls.
Mean body weights and clinical signs of control and
dosed rats and mice were comparable. Because no toxic
effects or consistent weight differences were observed,
the rats and mice may have been able to tolerate higher
doses.
In male rats with neoplastic nodules of the liver, the
dose response trend was positive (P<0.05) and the inci-
dence in the 3,000 ppm group was increased (P<0.05)
compared to controls (control, 5/90, 6%; low dose, 3/50,
6%; high dose, 8/50,16%). One male rat in the high dose
group had both a neoplastic nodule and a carcinoma of
the liver. This marginal increase in liver cell neoplasms
may have been associated with the dietary administra-
tion ofC.I. Acid Orange 10.
For both dose groups ofmale and female rats, leuke-
mia was significantly (P<0.05) decreased in a dose
related(P<0.005)trend(male:22/90,24%;4/50,8%;3/50,
6%; female: 16/88,18%; 2/50, 4%; 0/50).
No compound-related nonneoplastic or neoplastic
lesions were observed in the female rats or in mice of
either sex.
For 103 weeks C.I. Acid Orange 10 was given in the
diets ofmale andfemale F344/N rats (0,0.1, or0.3%) and
of male and female B6C3F1 mice (0, 0.3%, or 0.6%).
Under these conditions, there was no evidence of car-
cinogenicity formaleandfemale F344/N rats orformale
and female B6C3F1 mice.
Synonym: 7-hydroxy-8-(phenylazo)-1,3-naphthalenedi-
sulfonic acid, disodium salt
Report Date: October 1987
TR-212 Carcinogenesis Bioassay ofDi(2-
ethylhexyl)adipate (CAS No. 103-23-1) in
F344 Rats and B6C3F1 Mice (Feed Study)
Di(2-ethylhexyl)adipate is a plasticizer used to give
flexibility to vinyl plastics. A carcinogenesis bioassay
was conducted by feeding diets containing 12,000 or
25,000 ppm of di(2-ethylhexyl)adipate to groups of 50
male and 50 female F344 rats and 50male and 50female
B6C3F1 mice for 103 weeks. Groups of 50 undosed rats
and mice of each sex served as controls. All surviving
animals were killed at 104 to 107 weeks.
Mean body weights of high-dose rats and mice of
either sexwere lowerthanthose ofthecontrolsthrough-
out the study.
Compound administration was not associated with
tumor formation in F344 rats ofeither sex.
Hepatocellular carcinomas or adenomas occurred in
mice ofboth sexes in a dose-related fashion atincidences
that were significantly higher for high-dose males and
forlow- andhigh-dosefemales thanthoseinthecontrols.
When compared with the incidence in historical labora-
torycontrolmice, however, thelivertumors inmale mice
could notbe clearlyrelated to compound administration.
Under the conditions of this bioassay, di(2-
ethylhexyl)adipate was not carcinogenic for F344 rats.
Di(2-ethylhexyl)adipate was carcinogenic for female
B6C3F1 mice, causing increased incidences of
hepatocellular carcinomas, and was probably car-
cinogenic for male B6C3F1 mice, causing hepatocellular
adenomas.
Synonyms: bis(2-ethylhexyl)adipate; DEHA; octyl adi-
pate; diocytl adipate; DOA
Report Date: March 1982
TR-213 Carcinogenesis Bioassay ofButyl
Benzyl Phthalate (CAS No. 85-68-7) in
F344/N Rats and B6C3F1 Mice (Feed
Study)
Acarcinogenesis bioassay ofbutyl benzyl phthalate, a
plasticizer for vinyl chloride plastics, was accomplished
by feeding diets containing 6,000 or 12,000 ppm of the
phthalate to groups of 50 F344/N rats and 50 B6C3Fj
mice ofeach sex for 28 to 103 weeks.
Mean body weights of dosed female rats and mice of
each sex were lower than those of the control animals
throughout most ofthe study.
After week 14, an increasing number of dosed male
rats died as a result of an unexplained internal hemor-
rhaging, and all surviving male rats were killed atweek
29 to 30. Because of compound-related mortality, butyl
benzyl phthalate was not adequately tested for car-
cinogenicity in male F344/N rats.
Mononuclear cell leukemias occurred at a statistically
significant (P = 0.011) increased incidence in the high-
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dose group of female rats when compared with the
controlgroupandwithasignificantly(P=0.006)increas-
ing trend (controls 7/49, 14%; low-dose 7/49,14%; high-
dose 18/50, 36%). The incidence in the high-dose group
and the overall trend remained statistically significant
(P=0.008 and P=0.019)when comparedwith the histor-
ical incidence for F344/N female rats with leukemia at
this laboratory (77/ 399, 19%). Further, this leuko-
proliferation was generally characterized by
splenomegaly and often by hepatomegaly.
Administration ofbutylbenzylphthalatewasnotasso-
ciated with increased incidences of any type of tumor
among male or female mice.
Thmor rates were decreased in female rats for fibro-
adenomas of the mammary glands (20/49, 14/49, 9/50)
and in male mice for lymphomas of the hematopoietic
system (13/50, 11/49, 4/50) and for alveolar/bronchiolar
adenomas or carcinomas (17/50,11/49, 8/50).
Under the conditions of this bioassay, butyl benzyl
phthalate was probably carcinogenic for female F344/N
rats, causing an increased incidence ofmononuclear cell
leukemias. The male F344/N rat study was considered
inadequate for evaluation due to compound-related tox-
icity and earlymortality. Butyl benzyl phthalate was not
carcinogenic for B6C3F1 mice ofeither sex.
Synonyms: BBP; benzyl butyl phthalate; phthalic acid;
benzyl butyl ester; Santicizer 160
Report Date: August 1982
TR-214 Carcinogenesis Bioassay of
Caprolactam (CAS No. 105-60-2) in F344
Rats and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of caprolactam, a chemical
intermediate used in the production of nylon 6, was
conductedbyfeedingdietscontaining3,750 or7,500ppm
caprolactamtogroupsof50maleorfemale F344ratsand
7,500 or 15,000 ppm to groups of 50 male or female
B6C3F1 mice for 103 weeks. Control groups consisted of
50 undosed rats and 50 undosed mice ofeach sex.
Throughout the bioassay, mean bodyweight gains for
dosed rats and mice ofeither sex were decreased when
comparedwiththoseofthecontrols. Noothercompound-
related effects were observed.
Undertheconditions ofthisbioassay, caprolactamwas
not carcinogenic for F344 rats or B6C3F1 mice.
Synonyms: aminocaproic lactam; 2-oxohexamethyleni-
mine
Report Date: March 1982
TR-215 Carcinogenesis Bioassay of
Bisphenol A (CAS No. 80-05-7) in F344
Rats and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of bisphenol A, an inter-
mediate used in the manufacture of epoxy, polyearbo-
nate, and polyester-styrene resins, was conducted by
feeding diets containing 1,000 or 2,000 ppm of the test
chemical to groups of50 F344 rats ofeither sex, 1,000 or
5,000 ppm to groups of50 male B6C3F1 mice, and 5,000
or10,000ppmtogroupsof50femaleB6C3F1 micefor103
weeks. Groups of50rats and 50mice ofeithersexserved
as controls.
Mean body weights of rats of either sex and of high-
and low-dose female mice and high-dose male mice were
lower than those of the controls throughout the study.
Since food consumption of dosed female rats was only
70% to 80% that ofthe controls throughout most ofthis
study, reduced body weight gain was probably due to
reduced food consumption. Food consumption by dosed
male rats was 90% that of controls. Food consumption
among all groups ofmice appear to be similar.
Leukemias occurred at increased incidences in dosed
rats ofboth sexes. In male rats, the dose-related (13/50,
12/50,23/50)trendwasstatisticallysignificant(P=0.021)
by a Cochran-Armitage test, but neither the trend nor
theincreaseinthehigh-dosegroupwassignificantbylife
table analyses, which adjust for survival differences
among groups. Theincreased incidences in dosed female
rats were also not statistically significant (7/50, 13/50,
12/50).
Interstitial-cell tumorsofthetestesoccurredatstatis-
tically significant incidences in low- and high-dose male
rats; however, since this lesion normally occurs at a high
incidence in aging F344 male rats, the increased inci-
dence observed in this study was not considered com-
pound related (35/49, 48/50, 46/49).
In male mice, there was an increased incidence of
leukemias or lymphomas (2/49, 9/50, 5/50), but this
increase was not statistically significant.
Acompound-related increasedincidenceofmultinucle-
ated giant hepatocytes was observed in male mice (1/49,
41/49, 41/50), butthere was no increase ofliver tumors in
male mice.
The marginally significant increase in leukemias in
malerats,alongwithanincrease (notstatisticallysignifi-
cant)inleukemiasinfemaleratsandamarginallysignifi-
cant increase in the combined incidence of lymphomas
and leukemias in male mice, suggests that exposure to
bisphenol Amaybe associatedwith increased cancers of
the hematopoietic system. A statistically significant
increase in interstitial-cell tumors of the testes in male
rats was also suggestive of carcinogenesis, but was not
considered to be convincing evidence of a compound-
related effect because this lesion normally occurs at a
high incidence in aging F344 rats.
Under the conditions of this bioassay, there was no
convincing evidence that bisphenol A was carcinogenic
for F344 rats or B6C3F1 mice ofeither sex.
Synonym: 4,4'-isopropylidenediphenol
Report Date: March 1982
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TR-216 Carcinogenesis Bioassay of 11-
Aminoundecanoic Acid (CAS No. 2432-99-7)
in F344 Rats and B6C3F1 Mice
11-Aminoundecanoic acid is the monomer used in the
manufacture of the polyamide, nylon-11. Aminoun-
decanoic acid is synthesized through aseries ofreactions
from ricinoleic acid isolated from castor bean oil.
Nylon-11 is used in automobile parts, industrialfabrics
(e.g. filter bags, work clothes, and netting), and brushes
because of its resistance to vibration and shock and its
stability when in contact with fuels. Nylon-11 resins are
approved bythe U.S. Food and DrugAdministration for
use on food contact films.
A carcinogenesis bioassay of11-aminoundecanoic acid
was carried out by administering diets containing 7,500
or 15,000 ppm of 11-aminoundecanoic acid to F344 rats
andB6C3F1 mice.Groupsof50ratsand50miceofeither
sex were administered the test chemical for 104 weeks
(rats) or 103 weeks (mice). Controls consisted of 50
untreated rats and 50 untreated mice ofeach sex.
Nonneoplastic effects included dose-related decreases
in mean bodyweight gain and survival formale rats and
formiceofeachsex; adose-relatedincreasedincidenceof
hyperplasia of the transitional epithelium of the kidney
and urinary bladder in rats ofeach sex; and mineraliza-
tion ofthe kidney in dosed mice ofeach sex.
Neoplastic nodules of the liver in dosed male rats
(control1/50,2%;lowdose9/50,18%;highdose8/50,16%;
P<0.01) and transitional-cell carcinomas ofthe urinary
bladderinhigh-dosemalerats(control0/48,0%;lowdose
0/48, 0%; high dose 7/49, 14%: P<0.01) were observed at
significantly increased incidences compared with con-
trols. Malignant lymphomas occurred at a significantly
(P<0.05) increased rate in low-dose male mice (control
2/50, 4%; low dose 9/50, 18%; high dose 4/50, 8%).
Under the conditions of this bioassay, 11-
aminoundecanoic acid was carcinogenic for male F344
rats, inducing neoplastic nodules in the liver and
transitional-cell carcinomas in the urinary bladder. The
test chemical was not carcinogenic for female F344 rats.
Noclearevidencewasfoundforthecarcinogenicity of11-
aminoundecanoic acid in B6C3F1 mice of either sex,
although the increase in malignant lymphoma in male
micemayhavebeen associatedwith administration of11-
aminoundecanoic acid.
possible carcinogenicity was conducted by feeding diets
containing 6,000 or 12,000 ppm of the test chemical to
groups of50 male and 50 female F344 rats and 3,000 or
6,000 ppm to groups of 50 male and 50 female B6C3F1
mice for 103 weeks. Controls consisted of 50 untreated
rats and 50 untreated mice ofeither sex.
Meanbodyweights ofdosed male rats (high- and low-
dose), high-dose female rats, and dosed female mice
(high- and low-dose) were marginally-to-moderately
lowerthanthoseofthecorrespondingcontrols attheend
ofthechronicstudy,reflectingadecreaseinbodyweight
gain. Food consumption was reduced slightly in rats of
either sex, whereas there was no apparent difference
among the mouse groups.
Female rats and male and female mice administered
di(2-ethylhexyl)phthalate had significantly higher inci-
dencesofhepatocellularcarcinomasthanthose observed
in the controls (rats - males: 1/50, 2%; 1/49, 2%; 5/49,
10%; females - 0/50, 0%; 2/49, 4%; 8/50, 16%, P=0.003;
mice - males: 9/50, 18%; 14/48, 29%; 19/50, 38%,
P=0.022; females: 0/50, 0%; 7/50, 14%; P=0.006, 17/50,
34%,P<0.001).Further,astatisticallysignificantpositive
trend for hepatocellular carcinomas occurred in female
rats (P= 0.002) and in male (P= 0.018) and female
(P<0.001)mice.
In addition, di(2-ethylhexyl)phthalate caused a statis-
tically significant increased incidence of male rats with
either hepatocellular carcinomas or neoplastic nodules
(3/50, 6%; 6/49, 12%; 12/49, 24%; P=0.010).
Degeneration of the seminiferous tubules was
observed in the high-dose male rats (1/49, 2%; 2/44, 5%;
43/48, 90%) and in the high-dose male mice (1/49, 2%;
2/48 4%; 7/49,14%). Hypertrophy ofcells in the anterior
pituitary was also found at increased incidences in
the high-dose male rats (1/46, 2%; 0/43, 0%; 22/49,
45%).
Under the conditions of this bioassay, di(2-
ethylhexyl)phthalate was carcinogenic for F344 rats and
B6C3F1 mice, causing increased incidences of female
rats and male and female mice with hepatocellular car-
cinomas, and inducing an increased incidence of male
rats with either hepatocellular carcinomas or neoplastic
nodules.
Synonym: DEHP
Report Date: March 1982
Report Date: May 1982
TR-217 Carcinogenesis Bioassay ofDi(2-
ethylhexyl)phthalate (CAS No. 117-81-7) in
F344 Rats and B6C3F1 Mice (Feed Studies)
Abioassayofdi(2-ethylhexyl)phthalate, themostcom-
monlyusedplasticizerforpolyvinylchloridepolymers,for
TR-218 Monitoring Guidelines for the
Conduct ofCarcinogen Bioassays
Note to the Reader: This documentwas prepared as a
result of a discussion group on quality assurance con-
ducted at the National Cancer Institute in 1979.
Report Date: 1981
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TR-219 Carcinogenesis Bioassay of2,6-
Dichloro-p-Phenylenediamine (CAS No.
609-20-1) in F344 Rats and B6C3F1 Mice
(FeedStudy)
A carcinogenesis bioassay of 2,6-dichloro-p-
phenylenediamine, a chemical intermediate, was con-
ducted in groups of 50 F344 rats and B6C3F1 mice of
either sex. Male rats were fed diets containing 1,000 or
2,000 ppm 2,6-dichloro-p-phenylenediamine and female
ratswerefed2,000or6,000ppmfor103weeks. Micewere
fed 1,000 or3,000 ppm ofthe testchemical for 103weeks
and observed for an additional 8 weeks. Controls con-
sisted of50untreated rats and50untreatedmiceofeach
sex.
Throughout the study, mean body weights of dosed
rats and mice ofeither sex were lower than those ofthe
corresponding controls. A dose-related weight gain
depression was particularly pronounced for rats.
Ectopic hepatocytes were observed at an increased
incidence inthe pancreas and nephrosis was observed in
increased severity in dosed rats of either sex when
compared with the corresponding controls. No increase
inanytumortypewasobservedintreatedmaleorfemale
rats when compared to controls.
Increased incidences ofliver tumors were observed in
mice of both sexes. In male mice, the incidence of
hepatocellular adenomas exhibited a significant positive
dose-related trend (P=0.002), and the increased inci-
denceofhepatocellularadenomaswasstatisticallysignif-
icantinthe high-dose group (4/50, 7/50,15/50: P=0.005).
The combined incidence ofhepatocellular adenomas and
carcinomas showed a significant positive dose-related
trend (P=0.004) and was statistically significant in the
high-dose group (16/50, 19/50, 29/50: P=0.008).
In female mice, hepatocellular carcinomas exhibited a
significant positive dose-related trend (P=0.025), but no
singledosegrouphadastatisticallysignificantincreased
incidence ofeither adenomas (4/50, 4/50, 9/50; high-dose
effect: P=0.12) orcarcinomas(2/50,2/50,7/50; high-dose
effect: P = 0.08) alone. When the incidences of
hepatocellular adenomas and carcinomaswerecombined
(6/50,6/50,16/50), these data gave apositive dose-related
trend (P =0.004) and were statistically significant in the
high-dose group (P=0.014).
Under the conditions of this bioassay, 2,6-dichloro-
p-phenylenediamine was carcinogenic for male and
female B6C3F1 mice, causing increased incidences of
combined hepatocellular adenomas and carcinomas, and
formale B6C3F1 mice, causing anincreased incidence of
hepatocellular adenomas alone. 2,6-Dichloro-
p-phenylenediamine was not carcinogenic for male or
female F344 rats.
Report Date: March 1982
TR-220 Carcinogenesis Bioassay ofC.I.
Acid Red 14 (CAS No. 3567-69-9) in F344/N
Rats andB6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of textile grade C.I. Acid
Red 14 (67%-71% purity)was conductedbyfeeding diets
containing 6,000 or 12,500 ppm of this dye for 103-104
weeks to groups of 50 male F344 rats, 12,500 or 25,000
ppm to groups of50female F344 rats, and3,000 or6,000
ppmtogroupsof50B6C3F1 miceofeithersex.Groupsof
90 untreated rats ofeither sex and 50 untreated mice of
either sexserved as controls.
Throughout the study, mean body weights of dosed
ratsofeithersexanddosedfemalemicewerecomparable
withthose ofthecontrols,whilethemeanbodyweightof
high-dose male mice was slightly lower than that ofthe
controls.
Fourteen male rats in the low-dose group and 2 in the
high-dosegroupaccidentally drownedbetweenweeks84
and 103; 56% and 60% of these groups survived to
terminal kill compared with 78% ofthe controls. These
losses may have reduced the sensitivity of the assay in
malerats.
Ratsandmicemayhavetoleratedhigherdoses,butthe
slightdepressionofmeanbodyweightinhigh-dosemale
mice and the non-neoplastic lesions observed in dosed
female mice and in rats ofboth sexes suggestthat doses
administeredinthis studycouldbeconsideredmaximum
tolerateddoses.
Endometrial stromal polyps of the uterus were
observed inhigh-dosefemale rats at anincidence signifi-
cantly higher (P=0.008) than that seen in the controls
(controls: 9/87, 10%; low-dose: 11/50, 22%; high-dose:
14/50, 28%). However, the observed incidence of this
tumor in the dosed groups was similar to the historical
rate in untreated female F344 rats at this laboratory
(65/286, 23%; range 10%-37%). Hence, the increased
incidence of this lesion is not regarded as being associ-
ated with the administration ofC.I. Acid Red 14.
Administration ofC.I. Acid Red 14 tomicewas not as-
sociated with an increased incidence ofany tumor type.
Underthe conditions ofthisbioassay, C.I. Acid Red 14
was not carcinogenic for F344 rats or B6C3F1 mice of
eithersex.
Synonym: 4-hydroxy-3-(4-Sulfo-1-naphthalenyl)azo-1-
naphthalenesulfonic acid, disodium
Report Date: March 1982
TR-221 Carcinogenesis Bioassay of
Locust Bean Gum (CAS No. 9000-40-2) in
F344 Rats andB6C3F1 Mice (Feed Study)
Acarcinogenesisbioassayoflocustbeangum, awidely
used food stabilizer, was conducted by feeding diets
containing 25,000 or 50,000 ppm ofthe test substance to
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50 F344 rats and 50 B6C3F1 mice of either sex for 103
weeks. Groups of50untreatedratsandmiceofeithersex
served as controls.
Meanbodyweights ofhigh- andlow-doseratsofeither
sex, of low-dose male mice, and of high- and low-dose
female mice were comparable with those ofthe controls;
mean bodyweights ofhigh-dose malemicewere slightly
lowerthan those ofcontrols. No other compound-related
clinical signs or effects on survival were observed.
Although the rats and mice might have been able to
tolerate higher doses, 50,000 ppm (5%) is the recom-
mendedmaximumconcentration ofatestchemicalmixed
in feed according to the guidelines of the Bioassay
Program.
Although alveolar/bronchiolar adenomas occurred in
low-dose male mice at a significantly (P=0.017) higher
incidence than that in the controls (7/50,17/50,11150), no
significant statistical results were obtained when the
combined incidence of animals with either alveolar/
bronchiolar adenomas or carcinomas was analyzed
(14/50, 21V50, 14/50). Cortical adenomas in the adrenal
gland offemale rats occurred with a statistically signifi-
cant (P=0.042) positive trend (1V50, 4/50, 6/50), but com-
parisonsbetweentestgroups andthecontrolgroupwere
not statistically different.
Underthe conditions ofthisbioassay, locustbean gum
was not carcinogenic for male or female F344 rats or
B6C3F1 mice.
Report Date: February 1982
TR-222 Carcinogenesis Bioassay of
Disperse Yellow 3 (CAS No. 2832-40-8) in
F344 Rats and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of C.I. Disperse Yellow 3
(87.6% dye), atextiledye,was conductedbyfeedingdiets
containing 5,000 or 10,000 ppm of the test substance to
groupsof50F344ratsofeithersexfor103weeks.Similar
groups of 50 B6C3F1 mice received diets containing
2,500 or 5,000 ppm of the test substance for 103 weeks.
Groups of50 untreated rats and mice ofeach sex served
as controls.
Throughoutthebioassay, meanbodyweights ofdosed
rats and mice ofeither sex were lower than those ofthe
controls. Survival ofdosed rats ofeither sexwas signifi-
cantly greater than that of the corresponding controls.
No other compound-related clinical signs or effects on
survival were observed.
Asignificant increase inneoplastic nodules ofthe liver
occurred in dosed male rats as compared to controls
(controls 1149, 2%; low-dose 15/50, 30%; P<0.001; high-
dose, 10/50,20%; P<0.01). No increase was observed for
female rats.
Stomach tumors, rare in F344 rats (10/2960, 0.3%),
were found in the dosed male rats: one adenocarcinoma
and a sarcoma in a high-dose male and in the low-dose
group a squamous cell papilloma, fibrosarcoma, ade-
noma, and mucinous adenocarcinoma. The incidence of
these tumors was not significantly greater than that in
controls; thus, the association between the administra-
tion ofC.I. DisperseYellow3 and the stomach tumors in
male rats is not clearly established.
Negative trends in the incidences of certain primary
tumors in dosed rats included: decreased lymphocytic
leukemia in both sexes; decreased malignant meso-
thelioma and C-cell carcinoma of the thyroid in males;
and decreased pituitary chromophobe adenoma and
endometrial stromal polyps in females.
Hepatocellular adenomas occurred in dosed female
mice at incidences significantly higher than that in the
controls (control 0/50, 0%; low-dose 6/50, 12%, P<0.05;
high-dose 12/50, 24%, P<0.001). The incidences of
hepatocellular carcinomas were also higher in the dosed
female mice than in the controls, but the increased
incidences were not statistically significant (2/50, 4/50,
5/50). A significantly (P<0.05) lower incidence of
hepatocellular adenomas was detected among low-dose
(7/50, 149, 7/49) male mice.
Alveolar/bronchiolar adenomas occurred in high-dose
male mice at an incidence significantly (P<0.05) higher
thanthatinthe controls (control2/50,4%; low-dose 6/49,
12%; high-dose 9/49,18%). However, thehigh-doseeffect
was notsignificantwhenadenomasandcarcinomaswere
combined;theincidence amonglow-dosefemalemicewas
significantly reduced as compared with controls. Thus,
the incidence of alveolar/bronchiolar adenomas among
males is not considered to be related to treatment with
C.I. Disperse Yellow 3.
Malignant lymphomas occurred in a dose-related
(P<0.05) trend in female mice and at incidences greater
(P<0.05)inthehigh-dose groupthanthatinthecontrols
(10/50; 16/50; 19/50). However, because of the range of
variability in the historical incidence of this tumor and
because ofthe lack of a similar effect in male mice or in
male and female rats, this increase was not regarded as
beingunequivocally related to the administration ofC.I.
Disperse Yellow 3.
Under the conditions of this bioassay, C.I. Disperse
Yellow3wasconsideredtobecarcinogenicformaleF344
rats, causinganincreasedincidenceofneoplasticnodules
oftheliver;thisdyewasnotcarcinogenicforfemaleF344
rats. In addition, the stomach tumors found in the male
rats mayhave been induced bythe administration ofthe
test chemical. C.I. Disperse Yellow 3 was carcinogenic
for female B6C3F1 mice, as evidenced by the increased
incidence of hepatocellular adenomas; C.I. Disperse
Yellow 3 was not carcinogenic for male B6C3F1 mice.
Also, the increased incidence ofmalignant lymphoma in
female mice may have been associated with the admin-
istration ofC.I. Disperse Yellow 3.
Synonyms: Disperse FastYellow 6; Acetamine Yellow CG
Report Date: May 1982
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TR-223 Carcinogenesis Studies of
Eugenol (CAS No. 97-53-0) in F344/N Rats
andB6C3F1 Mice (Feed Studies)
Carcinogenesis studies of eugenol (>99% pure), a
widely used flavor additive and chemical intermediate,
were conducted by feeding diets containing 6,000 or
12,500ppmofeugenoltogroupsof50femaleF344/Nrats
and by feeding diets containing 3,000 or 6,000 ppm to
groups of50 male F344/N rats and B6C3F1 mice ofeach
sex for 103 weeks. Groups of40 rats and 50 mice ofeach
sex served as controls. Dose levels selected for the two
year studies were based on thirteen-week (91-day) stud-
ies in which dietary concentrations for the six groups
ranged from 0 to 12,500 ppm. Other than a -10% dif-
ference from controls in bodyweights in the 12,500 ppm
male rats, no chemicallyrelated gross or histopathologic
effects were observed.
In the two-year studies,with the exception ofthe high
dose female rats and female mice, final body weights of
the treated groups were comparable to their respective
controls. No significant differences in survival were
apparent for any of the eight groups receiving eugenol
and for the appropriate controls. Food consumption
among groups was not different in comparison with
controls - rats: males .97%,females >91%;mice: males
.94%,females>90%.
There were no significant observable differences
between treated and control groups of rats for either
nonneoplastic (toxic) lesions or neoplasms that could be
attributed to eugenol. Increases in tumor incidences
were diagnosed for low dose male rats with alveolar,
bronchiolar adenomas or carcinomas (combined), for
C-cell adenomas ofthe thyroid gland in low dose female
rats, and forendometrial stromal polyps ofthe uterus in
high dose female rats. Fibroadenomas ofthe mammary
gland were decreased in dosed groups of female rats
compared with controls. None ofthese differences were
considered tobe associatedwith the dietaryadministra-
tion ofeugenol.
In male mice, the low dose animals had an increased
incidence(P<0.05)ofbothhepatocellularadenomas(con-
trol, 4/50; low dose, 13/50; high dose, 10/49) and
hepatocellular carcinomas (10/50, 20/50, 9/49) when com-
pared with control animals. A significant increase in
hepatic neoplasms was not observed in high dose ani-
mals. No single liver tumor type was observed in female
mice with a statistically significant increased incidence.
When the incidences offemale mice with hepatocellular
adenoma or carcinoma were combined (2/50, 7/49, 9/49),
therewas adose-related positivetrend andtheincidence
ofliver neoplasms in high dose animals was higher than
incontrols (P<0.05).
Eugenol was given in the diets offemale F344/N rats
(0, 0.6, or 1.25%) and ofmale F344/N rats and male and
female B6C3F1 mice (0, 0.3, or 0.6%) for 103 weeks.
Under these experimental conditions, there was no evi-
dence ofcarcinogenicity observed for male or female
rats. For mice there was equivocal evidence of car-
cinogenicity since eugenol caused increased incidences
of both carcinomas and adenomas of the liver in male
mice at the 3,000 ppm dietary level and because eugenol
was associated with an increase in the combined inci-
dences of hepatocellular carcinomas or adenomas in
female mice.
Synonym: 1-allyl-3-methoxy-4-hydroxybenzene
Report Date: December 1983
TR-224 Carcinogenesis Bioassay of Tara
Gum (CAS No. 39300-88-4) in F344 Rats
and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of tara gum, a potential
stabilizer for cosmetics and foods, was conducted by
feeding diets containing 25,000 or 50,000 ppm ofthe test
substance to 50 F344 rats and 50 B6C3F1 mice ofeither
sexfor103weeks.Groupsof50untreatedratsandmiceof
either sex served as controls.
In the chronic bioassay, mean body weights of dosed
and control rats ofeither sex were comparable over the
course ofthe study. Feed consumption by low- and high-
dosemaleratswas92%and95%thatofthecontrols, and
feed consumption bylow- and high-dose female rats was
87% and 79% that ofthe controls. Mean bodyweights of
high-dose mice of either sex were lower than those of
controls; feed consumption by dosed mice was compar-
able with that of controls. Although the rats and mice
mighthavebeenabletotoleratehigherdoses,50,000ppm
(5%) is the recommended maximum concentration of a
testsubstance mixed infeed, according to the guidelines
ofthe Bioassay Program.
No tumorswere observed in increased incidences that
were considered to be related to administration of tara
gumtoeitherspecies. Interstitialcelltumorsofthetestis
inmaleratswereobservedinastatisticallysignificant(P
< 0.003 for trend and group comparisons) positive
relationship (40/48 controls; 46/46 low dose; 48/48 high
dose); because these tumors are present in almost all
agedF344maleratsandbecauseofthemarginalstatisti-
calsignificancewhentime-adjustedanalyses areapplied,
theseincreases are notregarded asbeingrelated to tara
gum administration.
Asignificant (P<0.05) negativetrendwas observed in
the proportion of male rats with pancreatic islet cell
adenoma (5/45 controls, 1/44 lowdose, 0/45 high dose), of
female mice with alveolar/bronchiolar adenomas (7/50,
2/49, 2/50), and of female mice with hepatocellular ade-
nomas (9/49, 4/49,1/50).
Under the conditions of this bioassay, tara gum was
not carcinogenic for F344 rats or B6C3F1 mice ofeither
sex.
Report Date: March 1982